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The top curve represents the number of cases diagnosed with AIDS using the 1993 definition criteria after
adjustments for reporting delays. It represents the distribution of all cases diagnosed with AIDS and illustrates the dis-
torting effect of the change in the case definition. The recent trend in AIDS incidence is no longer affected by the change
in the case definition but is affected by HIV treatments, largely beginning in 1996, as is the bottom curve which repre-
sents the reported number of deaths of persons with AIDS using the 1993 case definition after adjustments for reporting
delays.  It shows the continued decline in deaths of persons with AIDS.  [Graph by Debra L. Hanson, M.S.]
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Through December 1997, 641,086 persons with
AIDS have been reported to CDC (table 1).  From
1995 to 1996, for the first time in the epidemic, the oc-
currence of AIDS-defining opportunistic illnesses
(AIDS-OIs) among infected persons (tables 18-20)
and deaths among persons reported with AIDS (ta-
bles 21-23) decreased 7 percent and 25 percent, re-
spectively.  These declines were largely due to the
increasing use of combination antiretroviral therapy
including protease inhibitors.  Perinatally-acquired
AIDS incidence continued a pattern of marked decline
(table 20), principally reflecting successful strategies
to promote voluntary prenatal HIV testing and reduce
transmission rates through the administration of zi-
dovudine perinatally.  These treatment advances
have altered the natural history of HIV infection, con-
tributed to an increase in the number of persons living
with AIDS, and changed the shape of the epidemic
curves (see cover).  As therapy has improved the
health and prospects for AIDS-free survival among
HIV-infected persons who receive these new treat-
ment regimens, the ability of AIDS surveillance data to
represent the characteristics of affected populations
and project the need for resources for prevention and




 marks a transition in
how CDC will present HIV infection and AIDS data de-
picting the epidemic.
AIDS surveillance data will no longer be adjusted to
reflect the incidence of AIDS-OIs.  The incidence of
AIDS-OIs can no longer be estimated reliably be-
cause data are not currently available to model the in-
creasing effects of therapy on the rate of disease
progression.  The procedure was developed to take
into account the 1993 expansion of the AIDS case def-
inition which had a temporary distorting effect on the
AIDS incidence curve (see cover and technical notes).
Because of these limitations, the estimates of
AIDS-OI incidence in tables 18-20 will not be updated
past the end of 1996.  Instead, in future editions, CDC
will publish estimates of AIDS incidence based on the
incidence of all AIDS-defining conditions included in
the 1993 AIDS surveillance case definition.  AIDS
data will remain useful as a measure of severe
HIV-related morbidity in the population and to repre-
sent populations in which treatments have failed or
those which were not tested or treated prior to a diag-
nosis of AIDS.  
The proportion of AIDS and HIV infection cases ini-
tially reported without risk information has increased
in recent years.  Several factors have contributed to
this increase, including the greater  volume of cases
after the change in the AIDS case definition in 1993,
decreases in surveillance staff in some areas, and in-
creases in heterosexual transmission to persons (es-
pecially women) without recognizable high-risk
behaviors.  In the past, areas that conducted both HIV
infection and AIDS case reporting prioritized the com-
pletion of risk information for AIDS rather than HIV in-
fection cases.  Because of delays in completing these
data, trends in incidence, deaths, and prevalence by
risk/exposure category (tables 20, 23, 26) are pre-
sented using an estimation procedure that imputes
risk for cases initially reported without risk information.
The procedure is based on historical patterns of re-
classification after epidemiologic follow up (figure 7).
However, tables that present characteristics of report-
ed AIDS cases (tables 3-8, 15, 17) and of reported
HIV infection cases (tables 28-31) are not adjusted for
delays in reporting risk/exposure data.  The high per-
centage of recent cases that have no reported risk
poses difficulties in interpreting the meaning of the
proportionate distribution of cases by risk groups.  No
longer is it possible to compare differences in propor-
tions by risk group for the current year to the previous
year without estimating how the cases without risk in-
formation will eventually be reclassified.  Therefore, in





tables that present risk data for HIV infection and
AIDS cases will be revised to include adjustments for
unreported risk in order to enable readers of the report
to infer recent trends by risk group.
The trend data for AIDS-OI incidence, deaths, and
prevalence shown in tables 18-26 are adjusted for de-
lays in reporting of cases and deaths (see Technical
Notes).  These adjustments have been routinely ap-
plied when presenting trends in AIDS surveillance
data for many years, but not for HIV infection surveil-
lance data.  HIV infection case surveillance data are
currently reported from most, but not all states (table
27) and the HIV infection and AIDS case reporting
systems in these areas were only fully integrated in
late 1993.  Based on several years experience with
delays in reporting of HIV infection cases, delay ad-
justments for these data have been developed recent-








, trends in the number of new diagnoses of HIV
infection will be presented using these adjustment
procedures to enable readers of the report to interpret
more recent trends in the epidemic than are reflected
in AIDS surveillance data.
Most states and metropolitan statistical areas re-
ported a decrease in the number of AIDS cases re-
ported in 1997 compared to the number reported in
1996 (tables 1 and 2).  Whereas HIV infection and
AIDS incidence are unaffected by surveillance practic-
es, the reporting of HIV infection and AIDS cases to
state and territorial health departments can be affect-
ed by changes in staffing patterns, evaluation studies
which may identify previously unreported cases, or
other changes in state or local reporting practices.  In
addition to these effects, antiretroviral treatments are
changing the types of facilities where infected persons
may be diagnosed and treated.  Reporting areas are
experiencing a shift in AIDS case reporting from hos-
pital inpatient to outpatient settings.  Areas that rely
principally on case finding in hospitals may be missing
cases.  To ensure that persons eligible to be reported
as HIV infection or AIDS cases are accurately repre-
sented in the surveillance data, it is increasingly im-
portant that states and territories implement uniform
laboratory reporting methods to ascertain AIDS cases
that meet immunologic criteria and HIV infection cas-
es for those states that conduct HIV infection case re-
porting. To interpret unusual patterns in the number of





 should consult the
surveillance staff of the appropriate state or territorial
health department.
Since the beginning of the epidemic, CDC has pub-
lished data on the number and characteristics of AIDS
cases reported to CDC by state and territorial health
departments. Initially, data were published weekly to
help track this previously unrecognized and rapidly
burgeoning health threat.  Epidemiologic data quickly
identified the ways in which the epidemic was spread-
ing and the populations that were at greatest risk of
HIV infection.  With an increasing number of cases,
detecting changes in geographic, demographic, and
risk/exposure trends required longer periods of time,
and the AIDS data publication schedule was revised
to monthly, then quarterly, then semiannually.  The
ability of AIDS surveillance data to accurately depict
the distribution and characteristics of affected popula-
tions led to a reliance on these data to describe the
epidemic, identify populations in need of HIV preven-
tion programs, and target and allocate resources for
medical and other services for infected persons.
However, because treatments have affected AIDS in-
cidence rates among infected persons, CDC has stat-
ed that all states should implement HIV infection case
surveillance as an extension of their AIDS surveil-
lance programs.  HIV diagnoses are not affected by
treatment.  Although all infected persons in the popu-
lation may not seek or be offered HIV testing, the num-
ber of persons diagnosed with HIV infection together
with AIDS diagnoses provides a reliable minimum es-
timate of the number and characteristics of persons
who have accessed testing or care.  CDC estimates
that the majority of infected persons in the U.S. have
been tested.  The proportion tested among infected
persons in the population is expected to increase.  Ac-
cordingly, integrated HIV infection and AIDS case sur-
veillance data will be useful in planning and evaluating
prevention and treatment program needs and out-
comes.  
While the number and characteristics of reported
cases of HIV infection and AIDS in this edition remain
useful as a minimum estimate of the characteristics of
persons in need of services and treatment, the HIV/
AIDS surveillance system must evolve to meet public
health needs for data in a changing epidemic.  CDC
and state and territorial health departments are cur-
rently revising HIV infection and AIDS case finding
and reporting methods, changing how surveillance
data will be analyzed and  presented, and shifting the
focus of surveillance program activities from AIDS to
HIV infection including AIDS in order to be consistent
with current public health recommendations for early
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Table 1. AIDS cases and annual rates per 100,000 population, by state, reported in 1996 and 1997;
and cumulative totals, by state and age group, through December 1997, United States
 
1996 1997 Cumulative totals




< 13 years old Total 
 
Alabama 607 14.2 570 13.2 4,774 63 4,837
Alaska 36 6.0 52 8.5 407 5 412
Arizona 589 13.3 448 9.8 5,447 21 5,468
Arkansas 267 10.7 242 9.6 2,356 35 2,391
California 9,508 29.8 7,029 21.8 104,201 555 104,756
Colorado 518 13.6 380 9.8 6,103 27 6,130
Connecticut 1,110 34.0 1,222 37.4 9,566 172 9,738
Delaware 285 39.4 231 31.6 1,995 15 2,010
District of Columbia 1,258 233.3 998 188.7 10,255 154 10,409
Florida 7,293 50.6 6,098 41.6 63,617 1,289 64,906
Georgia 2,420 33.0 1,722 23.0 18,555 179 18,734
Hawaii 199 16.8 94 7.9 2,074 14 2,088
Idaho 38 3.2 52 4.3 415 2 417
Illinois 2,193 18.5 1,842 15.5 20,165 233 20,398
Indiana 590 10.1 523 8.9 4,904 34 4,938
Iowa 110 3.9 101 3.5 1,066 9 1,075
Kansas 230 8.9 159 6.1 1,978 10 1,988
Kentucky 401 10.3 361 9.2 2,562 21 2,583
Louisiana 1,463 33.7 1,094 25.1 10,096 112 10,208
Maine 50 4.0 51 4.1 797 9 806
Maryland 2,245 44.4 1,875 36.8 16,864 274 17,138
Massachusetts 1,303 21.4 863 14.1 12,714 198 12,912
Michigan 961 9.9 882 9.0 9,164 94 9,258
Minnesota 304 6.5 214 4.6 3,187 21 3,208
Mississippi 450 16.6 347 12.7 3,160 47 3,207
Missouri 853 15.9 577 10.7 7,773 54 7,827
Montana 34 3.9 41 4.7 265 3 268
Nebraska 99 6.0 91 5.5 870 9 879
Nevada 426 26.6 592 35.3 3,632 25 3,657
New Hampshire 93 8.0 55 4.7 759 8 767
New Jersey 3,580 44.7 3,226 40.1 35,417 693 36,110
New Mexico 206 12.0 169 9.8 1,607 5 1,612
New York 12,364 68.2 13,189 72.7 118,042 2,061 120,103
North Carolina 898 12.3 850 11.4 8,057 109 8,166
North Dakota 12 1.9 13 2.0 90 — 90
Ohio 1,156 10.4 848 7.6 9,453 112 9,565
Oklahoma 272 8.3 283 8.5 2,987 26 3,013
Oregon 460 14.4 305 9.4 4,147 16 4,163
Pennsylvania 2,340 19.4 1,912 15.9 19,058 265 19,323
Rhode Island 177 17.9 152 15.4 1,722 18 1,740
South Carolina 853 23.0 779 20.7 6,956 71 7,027
South Dakota 14 1.9 11 1.5 125 4 129
Tennessee 821 15.5 784 14.6 6,265 46 6,311
Texas 4,799 25.1 4,718 24.3 44,164 337 44,501
Utah 194 9.6 152 7.4 1,513 21 1,534
Vermont 25 4.3 29 4.9 325 3 328
Virginia 1,195 17.9 1,175 17.4 10,116 155 10,271
Washington 799 14.5 641 11.4 8,194 32 8,226
West Virginia 121 6.6 130 7.2 866 8 874
Wisconsin 271 5.3 255 4.9 3,009 25 3,034
Wyoming 7 1.5 16 3.3 155 2 157
 
Subtotal 66,497 25.1 58,443 21.8 611,989 7,701 619,690
U.S. dependencies, possessions, and associated nations
 
Guam 4 2.8 2 1.4 19 — 19
Pacific Islands, U.S. 1 0.3 1 0.3 4 — 4
Puerto Rico 2,241 59.2 2,040 53.3 20,241 370 20,611










U.S. totals presented in this report include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and
independent nations in free association with the United States. See Technical Notes.  Totals include 385 persons whose state of residence is unknown.
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Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with
500,000 or more population, reported in 1996 and 1997; and cumulative totals, by
area and age group, through December 1997, United States 
 
1996 1997 Cumulative totals 




<13 years old Total 
 
Akron, Ohio 57 8.4 75 11.0 449 — 449
Albany-Schenectady, N.Y. 179 20.4 218 24.9 1,428 21 1,449
Albuquerque, N.Mex. 115 17.2 102 15.1 898 2 900
Allentown, Pa. 113 18.5 61 9.9 662 8 670
Ann Arbor, Mich. 28 5.3 25 4.6 322 7 329
Atlanta, Ga. 1,651 46.8 1,173 32.3 13,208 95 13,303
Austin, Tex. 280 26.9 246 23.0 3,143 19 3,162
Bakersfield, Calif. 116 18.7 68 10.8 788 4 792
Baltimore, Md. 1,522 61.6 1,277 51.6 11,203 191 11,394
Baton Rouge, La. 329 58.1 197 34.6 1,379 18 1,397
Bergen-Passaic, N.J. 467 35.2 428 32.1 4,657 71 4,728
Birmingham, Ala. 206 23.0 174 19.3 1,498 19 1,517
Boston, Mass. 1,097 19.0 766 13.1 11,249 174 11,423
Buffalo, N.Y. 164 14.0 411 35.3 1,447 15 1,462
Charleston, S.C. 121 24.1 114 22.4 1,217 11 1,228
Charlotte, N.C. 182 13.8 145 10.7 1,622 21 1,643
Chicago, Ill. 1,838 23.8 1,568 20.2 17,485 207 17,692
Cincinnati, Ohio 211 13.2 184 11.4 1,669 14 1,683
Cleveland, Ohio 300 13.5 258 11.6 2,744 39 2,783
Columbia, S.C. 164 33.0 156 31.0 1,442 15 1,457
Columbus, Ohio 204 14.1 123 8.4 1,918 12 1,930
Dallas, Tex. 892 29.3 931 29.8 10,491 35 10,526
Dayton, Ohio 138 14.5 64 6.8 833 16 849
Denver, Colo. 390 20.9 292 15.4 4,902 19 4,921
Detroit, Mich. 702 15.8 555 12.4 6,330 67 6,397
El Paso, Tex. 113 16.5 131 18.7 785 9 794
Fort Lauderdale, Fla. 1,200 83.3 1,015 69.0 10,148 226 10,374
Fort Worth, Tex. 237 15.6 323 20.8 2,715 25 2,740
Fresno, Calif. 140 16.3 61 7.0 983 13 996
Gary, Ind. 78 12.6 73 11.7 578 3 581
Grand Rapids, Mich. 54 5.3 63 6.1 640 3 643
Greensboro, N.C. 119 10.4 88 7.6 1,287 19 1,306
Greenville, S.C. 143 16.0 108 11.9 1,130 2 1,132
Harrisburg, Pa. 86 14.0 125 20.3 757 6 763
Hartford, Conn. 376 34.0 471 42.6 3,313 46 3,359
Honolulu, Hawaii 137 15.8 75 8.6 1,521 11 1,532
Houston, Tex. 1,703 45.1 1,781 46.2 15,905 143 16,048
Indianapolis, Ind. 261 17.5 225 15.0 2,337 13 2,350
Jacksonville, Fla. 366 36.0 348 33.6 3,597 67 3,664
Jersey City, N.J. 533 97.0 510 92.5 5,710 112 5,822
Kansas City, Mo. 304 18.0 213 12.5 3,425 12 3,437
Knoxville, Tenn. 68 10.5 58 8.9 559 6 565
Las Vegas, Nev. 348 29.1 534 42.3 2,936 24 2,960
Little Rock, Ark. 92 16.8 98 17.7 870 13 883
Los Angeles, Calif. 3,654 40.2 2,629 28.7 36,815 223 37,038
Louisville, Ky. 232 23.5 183 18.4 1,213 14 1,227
McAllen, Tex. 40 8.1 33 6.5 258 7 265
Memphis, Tenn. 293 27.2 278 25.7 2,237 15 2,252
Miami, Fla. 2,049 100.6 1,672 81.8 19,480 450 19,930
Middlesex, N.J. 283 26.0 219 19.8 2,746 66 2,812
Milwaukee, Wis. 138 9.5 156 10.7 1,639 15 1,654
Minneapolis-Saint Paul, Minn. 275 10.0 184 6.6 2,819 17 2,836
Mobile, Ala. 84 16.1 106 20.1 921 11 932
Monmouth-Ocean, N.J. 240 22.6 196 18.2 2,456 59 2,515
Nashville, Tenn. 266 23.9 290 25.6 1,996 16 2,012
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Nassau-Suffolk, N.Y. 646 24.3 560 21.0 5,620 85 5,705
New Haven, Conn. 608 37.5 666 41.0 5,457 120 5,577
New Orleans, La. 765 58.5 564 43.1 5,722 56 5,778
New York, N.Y. 10,357 120.5 9,897 114.9 99,798 1,872 101,670
Newark, N.J. 1,424 73.5 1,356 69.8 14,255 298 14,553
Norfolk, Va. 435 28.3 411 26.6 2,855 57 2,912
Oakland, Calif. 631 28.2 479 21.1 7,000 41 7,041
Oklahoma City, Okla. 121 11.8 139 13.5 1,381 8 1,389
Omaha, Nebr. 74 10.9 65 9.5 617 3 620
Orange County, Calif. 431 16.5 270 10.1 4,757 27 4,784
Orlando, Fla. 525 36.8 537 36.6 4,688 71 4,759
Philadelphia, Pa. 1,669 33.7 1,492 30.2 14,589 214 14,803
Phoenix, Ariz. 373 13.5 274 9.6 3,833 13 3,846
Pittsburgh, Pa. 196 8.3 140 5.9 2,040 16 2,056
Portland, Oreg. 320 18.2 243 13.6 3,384 8 3,392
Providence, R.I. 167 18.4 143 15.8 1,614 17 1,631
Raleigh-Durham, N.C. 159 15.6 147 14.0 1,591 21 1,612
Richmond, Va. 237 25.4 220 23.3 2,035 25 2,060
Riverside-San Bernardino, Calif. 648 21.5 448 14.6 5,672 47 5,719
Rochester, N.Y. 288 26.5 363 33.4 1,953 12 1,965
Sacramento, Calif. 258 17.4 212 14.1 2,729 24 2,753
Saint Louis, Mo. 476 18.7 315 12.3 3,944 35 3,979
Salt Lake City, Utah 179 14.6 124 9.9 1,325 14 1,339
San Antonio, Tex. 382 25.7 303 20.0 3,316 27 3,343
San Diego, Calif. 978 36.5 800 29.4 9,058 50 9,108
San Francisco, Calif. 1,542 93.6 1,297 78.0 25,395 37 25,432
San Jose, Calif. 244 15.4 206 12.8 2,725 13 2,738
San Juan, P.R. 1,394 70.9 1,323 66.6 12,722 234 12,956
Sarasota, Fla. 109 20.5 107 19.9 1,151 21 1,172
Scranton, Pa. 38 6.1 39 6.3 358 4 362
Seattle, Wash. 580 26.1 370 16.3 5,868 18 5,886
Springfield, Mass. 199 33.7 96 16.2 1,330 23 1,353
Stockton, Calif. 54 10.1 55 10.1 611 13 624
Syracuse, N.Y. 115 15.4 221 29.8 1,064 7 1,071
Tacoma, Wash. 65 9.9 73 11.0 675 8 683
Tampa-Saint Petersburg, Fla. 791 36.0 609 27.3 6,837 89 6,926
Toledo, Ohio 76 12.4 43 7.0 491 10 501
Tucson, Ariz. 159 20.7 119 15.3 1,194 6 1,200
Tulsa, Okla. 87 11.5 85 11.1 915 8 923
Ventura, Calif. 106 14.8 46 6.3 685 2 687
Washington, D.C. 2,155 47.4 1,789 38.9 18,304 260 18,564
West Palm Beach, Fla. 842 84.5 620 60.9 5,961 187 6,148
Wichita, Kans. 77 14.7 55 10.4 583 2 585
Wilmington, Del. 239 43.5 195 35.1 1,596 10 1,606
Youngstown, Ohio 19 3.2 22 3.7 273 — 273
 
Metropolitan areas with 500,000 
or more population 56,616 33.9 49,395 29.3 532,731 6,859 539,590
 
Central counties 55,307 36.3 47,989 31.2 521,336 6,725 528,061
Outlying counties 1,188 8.1 1,292 8.6 10,178 123 10,301
 
Metropolitan areas with 50,000 
to 500,000 population 7,198 14.9 6,454 13.2 62,599 760 63,359
 
Central counties 6,701 15.8 6,039 14.1 58,696 694 59,390
Outlying counties 497 9.2 415 7.5 3,903 66 3,969
 









Totals include 2,929 persons whose area of residence is unknown.
 
Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with
500,000 or more population, reported in 1996 and 1997; and cumulative totals, by
area and age group, through December 1997, United States (continued)
 
1996 1997 Cumulative totals 




<13 years old Total 
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Table 3. AIDS cases by age group, exposure category, and sex, reported in 1996 and 1997;











exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Men who have sex with men 27,861 (51) 21,260 (45) – – – – 27,861 (41) 21,260 (35) 309,247 (49)
Injecting drug use 12,654 (23) 10,486 (22) 4,895 (36) 4,212 (32) 17,549 (26) 14,698 (24) 161,872 (26)
Men who have sex with men 
and inject drugs 3,269 ( 6) 2,374 ( 5) – – – – 3,269 ( 5) 2,374 ( 4) 40,534 ( 6)
Hemophilia/coagulation disorder 308 ( 1) 184 ( 0) 22 ( 0) 17 ( 0) 330 ( 0) 201 ( 0) 4,689 ( 1)
Heterosexual contact: 3,496 ( 6) 3,105 ( 7) 6,030 (44) 5,007 (38) 9,526 (14) 8,112 (13) 58,884 ( 9)
 
Sex with injecting drug user 913 749 2,047 1,475 2,960 2,224 24,128
Sex with bisexual male – – 338 266 338 266 2,887
Sex with person with hemophilia 7 4 37 24 44 28 401
Sex with transfusion recipient 
with HIV infection 37 28 65 29 102 57 893
Sex with HIV-infected person, 
risk not specified 2,539 2,324 3,543 3,213 6,082 5,537 30,575
 
Receipt of blood transfusion, 










6,504 (12) 9,423 (20) 2,547 (19) 3,684 (28) 9,051 (13) 13,107 (22) 49,560 ( 8)
Adult/adolescent subtotal 54,370 (100) 47,056 (100) 13,767 (100) 13,105 (100) 68,137 (100) 60,161 (100) 633,000 (100)
 
Pediatric (<13 years old) 
exposure category 
 
Hemophilia/coagulation disorder 4 ( 1) 1 ( 0) 1 ( 0) – – 5 ( 1) 1 ( 0) 233 ( 3)




311 (91) 235 (92) 310 (94) 197 (91) 621 (93) 432 (91) 7,335 (91)
 
Injecting drug use 84 65 77 42 161 107 2,936
Sex with an injecting drug user 43 31 44 29 87 60 1,340
Sex with a bisexual male 4 6 9 1 13 7 159
Sex with person with hemophilia 1 2 – – 1 2 28
Sex with transfusion recipient 
with HIV infection – – – – – – 24
Sex with HIV-infected person, 
risk not specified 57 53 59 49 116 102 1,033
Receipt of blood transfusion, 
blood components, or tissue 4 4 5 3 9 7 154
Has HIV infection, risk not 
specified 118 74 116 73 234 147 1,661
 
Receipt of blood transfusion, 




5 ( 1) 1 ( 0) 3 ( 1) 1 ( 0) 8 ( 1) 2 ( 0) 374 ( 5)




21 ( 6) 19 ( 7) 16 ( 5) 19 ( 9) 37 ( 6) 38 ( 8) 144 ( 2)
Pediatric subtotal 341 (100) 256 (100) 330 (100) 217 (100) 671 (100) 473 (100) 8,086 (100)
 












Thirty-seven adults/adolescents and 2 children developed AIDS after receiving blood screened negative for HIV antibody. Thirteen additional adults developed
AIDS after receiving tissue, organs, or artificial insemination from HIV-infected donors. Four of the 13 received tissue, organs, or artificial insemination from a
donor who was negative for HIV antibody at the time of donation. See 
 






See table 16 and figure 7 for a discussion of the "other" exposure category. "Other" also includes 82 persons who acquired HIV infection perinatally but were
diagnosed with AIDS after age 13. These 82 persons are tabulated under the adult/adolescent, not pediatric, exposure category.
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Table 4. Male adult/adolescent AIDS cases by exposure category and race/ethnicity, 
reported in 1997, and cumulative totals, through December 1997, United States
 








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 11,787 (67) 199,776 (75) 5,749 (30) 64,879 (38) 3,355 (34) 40,399 (43)
Injecting drug use 2,008 (11) 23,905 ( 9) 5,494 (29) 60,118 (35) 2,895 (30) 34,063 (36)
Men who have sex with men 
and inject drugs 1,078 ( 6) 21,066 ( 8) 897 ( 5) 12,842 ( 8) 367 ( 4) 6,230 ( 7)
Hemophilia/coagulation disorder 137 ( 1) 3,509 ( 1) 26 ( 0) 490 ( 0) 17 ( 0) 390 ( 0)
Heterosexual contact: 545 ( 3) 4,178 ( 2) 1,740 ( 9) 11,464 ( 7) 776 ( 8) 4,674 ( 5)
 
Sex with an injecting drug user 155 1,599 416 4,252 171 1,430
Sex with person with hemophilia – 23 2 12 2 8
Sex with transfusion recipient
with HIV infection 10 142 15 130 3 75
Sex with HIV-infected person, 
risk not specified 380 2,414 1,307 7,070 600 3,161
 
Receipt of blood tranfusion, 
blood components, or tissue 108 ( 1) 3,059 ( 1) 72 ( 0) 989 ( 1) 38 ( 0) 539 ( 1)




1,986 (11) 9,159 ( 3) 4,925 (26) 19,359 (11) 2,330 (24) 7,289 ( 8)
 
Total 17,649 (100) 264,652 (100) 18,903 (100) 170,141 (100) 9,778 (100) 93,584 (100)











Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 229 (60) 3,020 (75) 79 (47) 868 (59) 21,260 (45) 309,247 (58)
Injecting drug use 25 ( 7) 214 ( 5) 33 (20) 224 (15) 10,486 (22) 118,658 (22)
Men who have sex with men and
 inject drugs 12 ( 3) 138 ( 3) 19 (11) 242 (16) 2,374 ( 5) 40,534 ( 8)
Hemophilia/coagulation disorder 3 ( 1) 62 ( 2) 1 ( 1) 26 ( 2) 184 ( 0) 4,483 ( 1)
Heterosexual contact: 24 ( 6) 119 ( 3) 12 ( 7) 37 ( 3) 3,105 ( 7) 20,493 ( 4)
 
Sex with an injecting drug user 5 31 1 13 749 7,328
Sex with person with hemophilia – – – – 4 43
Sex with transfusion recipient 
with HIV infection – 7 – 1 28 356
Sex with HIV-infected person, 
risk not specified 19 81 11 23 2,324 12,766
 
Receipt of blood tranfusion, 
blood components, or tissue 4 ( 1) 101 ( 3) 2 ( 1) 8 ( 1) 224 ( 0) 4,705 ( 1)
Risk not reported or identified 84 (22) 383 ( 9) 22 (13) 72 ( 5) 9,423 (20) 36,412 ( 7)
 








Includes 641 men whose race/ethnicity is unknown.
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Table 5. Female adult/adolescent AIDS cases by exposure category and race/ethnicity, 
reported in 1997, and cumulative totals, through December 1997, United States
 








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Injecting drug use 907 (36) 9,614 (43) 2,511 (32) 24,981 (45) 750 (29) 8,359 (42)
Hemophilia/coagulation disorder 2 ( 0) 91 ( 0) 10 ( 0) 74 ( 0) 3 ( 0) 36 ( 0)
Heterosexual contact: 991 (40) 8,838 (39) 2,790 (35) 19,981 (36) 1,174 (46) 9,193 (46)
 
Sex with injecting drug user 316 3,734 779 8,402 368 4,531
Sex with bisexual male 102 1,277 114 1,091 42 440
Sex with person with hemophilia 16 257 7 65 1 30
Sex with transfusion recipient 
with HIV infection 10 279 13 147 5 93
Sex with HIV-infected person, 
risk not specified 547 3,291 1,877 10,276 758 4,099
 
Receipt of blood transfusion, 
blood components, or tissue 39 ( 2) 1,739 ( 8) 112 ( 1) 1,146 ( 2) 28 ( 1) 517 ( 3)




546 (22) 2,181 (10) 2,457 (31) 9,009 (16) 623 (24) 1,789 ( 9)
 
Total 2,485 (100) 22,463 (100) 7,880 (100) 55,191 (100) 2,578 (100) 19,894 (100)











Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Injecting drug use 11 (17) 87 (17) 14 (39) 128 (46) 4,212 (32) 43,214 (44)
Hemophilia/coagulation disorder 1 ( 2) 4 ( 1) 1 ( 3) 1 ( 0) 17 ( 0) 206 ( 0)
Heterosexual contact: 30 (47) 239 (47) 13 (36) 105 (38) 5,007 (38) 38,391 (39)
 
Sex with injecting drug user 7 69 4 54 1,475 16,800
Sex with bisexual male 5 58 2 15 266 2,887
Sex with person with hemophilia – 4 – 2 24 358
Sex with transfusion recipient 
with HIV infection 1 17 – – 29 537
Sex with HIV-infected person, 
risk not specified 17 91 7 34 3,213 17,809
 
Receipt of blood transfusion, 
blood components, or tissue 4 ( 6) 91 (18) 1 ( 3) 13 ( 5) 185 ( 1) 3,509 ( 4)
Risk not reported or identified 18 (28) 87 (17) 7 (19) 32 (11) 3,684 (28) 13,148 (13)
 








Includes 133 women whose race/ethnicity is unknown.
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Table 6. Pediatric AIDS cases by exposure category and race/ethnicity, reported in 1997, and
cumulative totals, through December 1997, United States
 








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder – – 157 (11) 1 ( 0) 35 ( 1) – – 37 ( 2)
Mother with/at risk for HIV infection: 59 (94) 1,061 (74) 261 (89) 4,478 (95) 104 (95) 1,725 (92)
 
Injecting drug use 19 445 61 1,768 25 700
Sex with injecting drug user 13 207 27 662 19 459
Sex with bisexual male 4 65 2 55 1 37
Sex with person with hemophilia 1 17 – 5 1 6
Sex with transfusion recipient 
with HIV infection – 9 – 8 – 7
Sex with HIV-infected person, 
risk not specified 10 123 61 669 29 227
Receipt of blood transfusion, 
blood components, or tissue 2 43 2 77   3 33
Has HIV infection, risk not specified 10 152 108 1,234 26 256
 
Receipt of blood transfusion, blood 
components, or tissue – – 183 (13) – – 89 ( 2) 2 ( 2) 92 ( 5)




4 ( 6) 25 ( 2) 30 (10) 95 ( 2) 4 ( 4) 22 ( 1)
 
Total 63 (100) 1,426 (100) 292 (100) 4,697 (100) 110 (100) 1,876 (100)












Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder – – 3 ( 7) – – 1 ( 4) 1 ( 0) 233 ( 3)
Mother with/at risk for HIV infection: 3 (100) 30 (68) 2 (100) 26 (96) 432 (91) 7,335 (91)
 
Injecting drug use – 4 – 12 107 2,936
Sex with injecting drug user – 4 1 7 60 1,340
Sex with bisexual male – 2 – – 7 159
Sex with person with hemophilia – – – – 2 28
Sex with transfusion recipient 
with HIV infection – – – – – 24
Sex with HIV-infected person, 
risk not specified 1 9 1 3 102 1,033
Receipt of blood transfusion, 
blood components, or tissue – 1 – – 7 154
Has HIV infection, risk not specified 2 10 – 4 147 1,661
 
Receipt of blood transfusion, blood
components, or tissue – – 10 (23) – – – – 2 ( 0) 374 ( 5)
Risk not reported or identified – – 1 ( 2) – – – – 38 ( 8) 144 ( 2)
 








Includes16 children whose race/ethnicity is unknown.
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Table 7. AIDS cases in adolescents and adults under age 25, by sex and exposure 
category, reported in 1996 and 1997; and cumulative totals through 
December 1997, United States
 






Male exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 75 (35) 70 (36) 652 (34) 836 (61) 627 (55) 10,569 (63)
Injecting drug use 13 ( 6) 9 ( 5) 118 ( 6) 152 (11) 126 (11) 2,101 (12)
Men who have sex with men 
and inject drugs 3 ( 1) 11 ( 6) 92 ( 5) 86 ( 6) 50 ( 4) 1,767 (10)
Hemophilia/coagulation disorder 56 (26) 21 (11) 725 (37) 43 ( 3) 22 ( 2) 602 ( 4)
Heterosexual contact: 19 ( 9) 14 ( 7) 69 ( 4) 101 ( 7) 79 ( 7) 706 ( 4)
 
Sex with injecting drug user 3 2 18 14 16 241
Sex with person with hemophilia – – 1 1 – 4
Sex with transfusion recipient 
with HIV infection 1 – 1 – – 11
Sex with HIV-infected person, 
risk not specified 15 12 49 86 63 450
 
Receipt of blood transfusion,
blood components, or tissue 10 ( 5) 10 ( 5) 83 ( 4) 8 ( 1) 1 ( 0) 104 ( 1)




41 (19) 57 (30) 195 (10) 149 (11) 245 (21) 1,050 ( 6)
Male subtotal 217 (100) 192 (100) 1,934 (100) 1,375 (100) 1,150 (100) 16,899 (100)
Female exposure category 
Injecting drug use 15 ( 8) 12 ( 6) 170 (14) 137 (17) 100 (14) 1,717 (28)
Hemophilia/coagulation disorder – – – – 10 ( 1) 1 ( 0) 1 ( 0) 14 ( 0)
Heterosexual contact: 90 (49) 78 (42) 631 (53) 480 (60) 362 (51) 3,264 (54)
Sex with injecting drug user 19 16 237 138 79 1,388
Sex with bisexual male 4 4 34 27 20 237
Sex with person with hemophilia – – 13 5 1 52
Sex with transfusion recipient 
with HIV infection 1 – 2 5 1 22
Sex with HIV-infected person, 
risk not specified 66 58 345 305 261 1,565
Receipt of blood transfusion, 
blood components, or tissue 12 ( 7) 11 ( 6) 83 ( 7) 8 ( 1) 5 ( 1) 113 ( 2)
Risk not reported or identified 67 (36) 86 (46) 302 (25) 179 (22) 237 (34) 946 (16)
Female subtotal 184 (100) 187 (100) 1,196 (100) 805 (100) 705 (100) 6,054 (100)
Total 401 379 3,130 2,180 1,855 22,953
1See figure 7.
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Table 8. AIDS cases by age at diagnosis and exposure category, reported through December
1997, United States
Age at diagnosis (years)




Men who have 







No. (%) No. (%) No. (%) No. (%) No. (%)
Under 5 — — — — — — 12 ( 0) — —
5-12 — — — — — — 221 ( 4) — —
13-19 652 ( 0) 288 ( 0) 92 ( 0) 735 (15) 700 ( 1)
20-24 10,569 ( 3) 3,818 ( 2) 1,767 ( 4) 616 (13) 3,970 ( 7)
25-29 47,061 (15) 16,685 (10) 7,268 (18) 753 (15) 9,928 (17)
30-34 75,431 (24) 35,508 (22) 11,461 (28) 718 (15) 12,921 (22)
35-39 67,638 (22) 43,706 (27) 9,995 (25) 590 (12) 11,066 (19)
40-44 47,609 (15) 34,107 (21) 5,732 (14) 437 ( 9) 7,526 (13)
45-49 28,769 ( 9) 16,391 (10) 2,564 ( 6) 310 ( 6) 4,821 ( 8)
50-54 15,722 ( 5) 6,601 ( 4) 1,013 ( 2) 174 ( 4) 3,129 ( 5)
55-59 8,586 ( 3) 2,897 ( 2) 417 ( 1) 117 ( 2) 2,093 ( 4)
60-64 4,449 ( 1) 1,176 ( 1) 154 ( 0) 104 ( 2) 1,327 ( 2)
65 or older 2,761 ( 1) 695 ( 0) 71 ( 0) 135 ( 3) 1,402 ( 2)
Total 309,247 (100) 161,872 (100) 40,534 (100) 4,922 (100) 58,884 (100)









No. (%) No. (%) No. (%) No. (%)
Under 5 139 ( 2) 6,114 (82) 78 ( 0) 6,343 ( 1)
5-12 235 ( 3) 1,221 (16) 66 ( 0) 1,743 ( 0)
13-19 166 ( 2) 82 ( 1) 415 ( 1) 3,130 ( 0)
20-24 217 ( 3) — — 1,996 ( 4) 22,953 ( 4)
25-29 595 ( 7) — — 6,125 (12) 88,415 (14)
30-34 877 (10) — — 9,796 (20) 146,712 (23)
35-39 912 (11) — — 9,474 (19) 143,381 (22)
40-44 855 (10) — — 7,394 (15) 103,660 (16)
45-49 669 ( 8) — — 4,992 (10) 58,516 ( 9)
50-54 687 ( 8) — — 3,463 ( 7) 30,789 ( 5)
55-59 668 ( 8) — — 2,473 ( 5) 17,251 ( 3)
60-64 796 ( 9) — — 1,656 ( 3) 9,662 ( 2)
65 or older 1,772 (21) — — 1,694 ( 3) 8,530 ( 1)
Total2 8,588 (100) 7,417 (100) 49,622 (100) 641,086 (100)
1See figure 7.
2Totals include 1 person whose age at diagnosis unknown.
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Table 9. AIDS cases by sex, age at diagnosis, and race/ethnicity, reported through December
1997, United States
Male









No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Under 5 490 ( 0) 1,953 ( 1) 722 ( 1) 15 ( 0) 11 ( 1) 3,194 ( 1)
5-12 317 ( 0) 395 ( 0) 250 ( 0) 9 ( 0) 3 ( 0) 977 ( 0)
13-19 793 ( 0) 695 ( 0) 407 ( 0) 21 ( 1) 16 ( 1) 1,934 ( 0)
20-24 7,100 ( 3) 5,977 ( 3) 3,594 ( 4) 142 ( 3) 66 ( 4) 16,899 ( 3)
25-29 35,308 (13) 21,938 (13) 14,218 (15) 494 (12) 278 (19) 72,317 (13)
30-34 62,333 (23) 36,728 (21) 22,768 (24) 892 (22) 402 (27) 123,255 (23)
35-39 59,989 (23) 39,336 (23) 21,117 (22) 891 (22) 320 (21) 121,806 (23)
40-44 43,566 (16) 30,260 (18) 14,611 (15) 713 (18) 221 (15) 89,491 (17)
45-49 26,087 (10) 16,852 (10) 8,040 ( 9) 408 (10) 94 ( 6) 51,541 (10)
50-54 13,987 ( 5) 8,705 ( 5) 4,197 ( 4) 224 ( 6) 33 ( 2) 27,177 ( 5)
55-59 7,646 ( 3) 4,864 ( 3) 2,343 ( 2) 141 ( 3) 25 ( 2) 15,042 ( 3)
60-64 4,289 ( 2) 2,652 ( 2) 1,281 ( 1) 58 ( 1) 15 ( 1) 8,307 ( 2)
65 or older 3,554 ( 1) 2,134 ( 1) 1,008 ( 1) 53 ( 1) 7 ( 0) 6,762 ( 1)
Male subtotal 265,459 (100) 172,489 (100) 94,556 (100) 4,061 (100) 1,491 (100) 538,703 (100)
Female
Age at diagnosis (years)
Under 5 462 ( 2) 1,940 ( 3) 714 ( 3) 13 ( 2) 13 ( 4) 3,149 ( 3)
5-12 157 ( 1) 409 ( 1) 190 ( 1) 7 ( 1) — — 766 ( 1)
13-19 199 ( 1) 789 ( 1) 200 ( 1) 6 ( 1) 1 ( 0) 1,196 ( 1)
20-24 1,374 ( 6) 3,358 ( 6) 1,258 ( 6) 32 ( 6) 26 ( 9) 6,054 ( 6)
25-29 3,925 (17) 8,580 (15) 3,470 (17) 66 (13) 45 (15) 16,098 (16)
30-34 5,320 (23) 12,969 (23) 4,950 (24) 103 (20) 72 (25) 23,457 (23)
35-39 4,532 (20) 12,656 (22) 4,200 (20) 96 (18) 57 (20) 21,575 (21)
40-44 2,897 (13) 8,479 (15) 2,678 (13) 72 (14) 31 (11) 14,169 (14)
45-49 1,526 ( 7) 3,930 ( 7) 1,428 ( 7) 53 (10) 23 ( 8) 6,975 ( 7)
50-54 839 ( 4) 1,965 ( 3) 766 ( 4) 25 ( 5) 13 ( 4) 3,612 ( 4)
55-59 587 ( 3) 1,120 ( 2) 475 ( 2) 16 ( 3) 6 ( 2) 2,209 ( 2)
60-64 409 ( 2) 675 ( 1) 249 ( 1) 19 ( 4) 3 ( 1) 1,355 ( 1)
65 or older 855 ( 4) 670 ( 1) 220 ( 1) 20 ( 4) 2 ( 1) 1,768 ( 2)
Female subtotal 23,082 (100) 57,540 (100) 20,798 (100) 528 (100) 292 (100) 102,383 (100)
Total2 288,541 230,029 115,354 4,589 1,783 641,086
1Includes 647 males and 143 females whose race/ethnicity is unknown.
2Includes 1 male whose age at diagnosis is unknown.
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Table 10. AIDS cases and annual rates per 100,000 population, by race/ethnicity, age group





Race/ethnicity No. Rate No. Rate No. Rate No. Rate No. Rate
White, not Hispanic 17,649 22.5 2,485 3.0 20,134 12.4 63 0.2 20,197 10.4
Black, not Hispanic 18,903 163.4 7,880 58.8 26,783 107.2 292 4.0 27,075 83.7
Hispanic 9,778 78.5 2,578 21.5 12,356 50.6 110 1.3 12,466 37.7
Asian/Pacific Islander 381 10.2 64 1.5 445 5.6 3 0.1 448 4.5
American Indian/Alaska Native 168 23.0 36 4.7 204 13.6 2 0.4 206 10.4
Total1 47,056 44.0 13,105 11.5 60,161 27.3 473 0.9 60,634 22.3
1Totals include 242 persons whose race/ethnicity is unknown.
Table 11. AIDS cases by year of diagnosis and definition category, diagnosed through 
December 1997, United States
Period of diagnosis
Before
1994 1994 1995 1996 1997
Cumulative
total
Definition category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Pre-1987 definition 251,159 (60) 23,542 (33) 18,511 (28) 13,002 (24) 6,358 (20) 312,572 (49)
1987 definition 96,600 (23) 12,550 (18) 10,228 (15) 7,543 (14) 3,752 (12) 130,673 (20)
1993 definition1 70,076 (17) 35,117 (49) 37,494 (57) 34,111 (62) 21,043 (68) 197,841 (31)
Pulmonary tuberculosis 5,725 1,607 1,282 955 456 10,025
Recurrent pneumonia 2,301 980 912 668 345 5,206
Invasive cervical cancer 307 141 89 56 26 619
Severe HIV-related 
immunosuppression2 61,880 32,441 35,239 32,454 20,224 182,238
Total 417,835 (100) 71,209 (100) 66,233 (100) 54,656 (100) 31,153 (100) 641,086 (100)
1The sum of diagnoses listed for the four conditions under the 1993 definition do not equal the 1993 definition total because some persons have more
than one diagnosis from the added conditions of pulmonary tuberculosis, recurrent pneumonia, and invasive cervical cancer.
2Defined as CD4+ T-lymphocyte count of less than 200 cells/µL or a CD4+ percentage less than 14 in persons with laboratory confirmation of HIV
infection.
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Table 12. AIDS-indicator conditions reported in 1997, by age group, United States
Adults/adolescents Children <13 years old
AIDS-indicator conditions No. (%) No. (%)
AIDS-defining opportunistic illness1 23,527 (39) 473 (100)
Bacterial infections, multiple or recurrent NA2 84 (18)
Candidiasis of bronchi, trachea, or lungs 534 ( 2) 11 ( 2)
Candidiasis of esophagus
Definitive diagnosis 2,057 ( 9) 30 ( 6)
Presumptive diagnosis 1,255 ( 5) 20 ( 4)
Carcinoma, invasive cervical 144 ( 1) NA3
Coccidioidomycosis, disseminated or extrapulmonary 74 ( 0) 1 ( 0)
Cryptococcosis, extrapulmonary 1,168 ( 5) 5 ( 1)
Cryptosporidiosis, chronic intestinal 314 ( 1) 10 ( 2)
Cytomegalovirus disease other than retinitis 827 ( 4) 30 ( 6)
Cytomegalovirus retinitis
Definitive diagnosis 551 ( 2) 4 ( 1)
Presumptive diagnosis 260 ( 1) 5 ( 1)
Herpes simplex, with esophagitis, pneumonitis, or chronic mucocutaneous ulcers 1,250 ( 5) 15 ( 3)
Histoplasmosis, disseminated or extrapulmonary 208 ( 1) 1 ( 0)
HIV encephalopathy (dementia) 1,196 ( 5) 108 (23)
HIV wasting syndrome 4,212 (18) 73 (15)
Isosporiasis, chronic intestinal 22 ( 0) 1 ( 0)
Kaposi’s sarcoma
Definitive diagnosis 1,088 ( 5) — —
Presumptive diagnosis 412 ( 2) — —
Lymphoid interstitial pneumonia and/or pulmonary lymphoid hyperplasia
Definitive diagnosis NA2 23 (5)
Presumptive diagnosis NA2 57 (12)
Lymphoma, Burkitt's (or equivalent term) 162 ( 1) 2 ( 0)
Lymphoma, immunoblastic (or equivalent term) 518 ( 2) 3 ( 1)
Lymphoma, primary in brain 170 ( 1) 1 ( 0)
Mycobacterium avium or  M. kansasii, disseminated or extrapulmonary
Definitive diagnosis 941 ( 4) 22 ( 5)
Presumptive diagnosis 183 ( 1) 10 ( 2)
M. tuberculosis, disseminated or extrapulmonary
Definitive diagnosis 426 ( 2) 1 ( 0)
Presumptive diagnosis 65 ( 0) 1 ( 0)
M. tuberculosis, pulmonary
Definitive diagnosis 1,426 ( 6) NA3
Presumptive diagnosis 195 ( 1) NA3
Mycobacterial disease, other, disseminated or extrapulmonary
Definitive diagnosis 221 ( 1) 4 ( 1)
Presumptive diagnosis 80 ( 0) — —
Pneumocystis carinii  pneumonia
Definitive diagnosis 5,763 (24) 77 (16)
Presumptive diagnosis 3,382 (14) 41 ( 9)
Pneumonia, recurrent
Definitive diagnosis 1,044 ( 4) NA3
Presumptive diagnosis 303 ( 1) NA3
Progressive multifocal leukoencephalopathy 213 ( 1) 1 ( 0)
Salmonella septicemia, recurrent 68 ( 0) NA4
Toxoplasmosis of brain
Definitive diagnosis 576 ( 2) 1 ( 0)
Presumptive diagnosis 497 ( 2) 2 ( 0)
Immunosuppression, severe HIV-related5 36,634 (61) NA3
Total 60,161 (100) 473 (100)
1Percentages for individual AIDS-defining opportunistic illnesses are based upon  23,527 adults/adolescents and 473 children reported to CDC in 1997,
with at least one of the illnesses listed above.  The sum of percentages is greater than 100 because some patients are reported with more than one ill-
ness.  Of persons reported with AIDS-defining opportunistic illnesses, 65 percent also were reported with severe HIV-related immunosuppression.
2Not applicable as indicator of AIDS in adults/adolescents.
3Not applicable as indicator of AIDS in children.
4Tabulated above in "bacterial infections, multiple or recurrent."
5Defined as a CD4+ T-lymphocyte count of less than 200 cells/µL or a CD4+ percentage less than 14 in adults/adolescents who meet the AIDS surveil-
lance case definition.  In 1997, 51,991 adults/adolescents were reported with severe HIV-related immunosuppression.  The 36,634 adults/adoles-
cents presented on this table are those persons reported with immunosuppression as their only AIDS-indicator condition.  These persons may also
have other AIDS-indicator conditions that are unreported.
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Table 13. AIDS cases, case-fatality rates, and deaths, by half-year and age group, through
December 1997, United States1














Before 1981 85 91.8 30 8 75.0 1
1981 Jan.–June 108 88.9 37 10 80.0 2
July–Dec. 208 93.8 83 6 100.0 6
1982 Jan.–June 440 93.2 151 14 92.9 10
July–Dec. 730 92.3 298 17 82.4 4
1983 Jan.–June 1,349 94.3 528 33 100.0 14
July–Dec. 1,719 94.2 950 44 93.2 16
1984 Jan.–June 2,700 93.6 1,427 53 88.7 27
July–Dec. 3,516 94.2 2,027 66 87.9 24
1985 Jan.–June 5,185 92.9 2,875 111 82.9 47
July–Dec. 6,555 93.5 3,979 139 87.8 71
1986 Jan.–June 8,713 92.4 5,208 144 85.4 70
July–Dec. 10,264 93.0 6,734 198 80.8 98
1987 Jan.–June 13,579 91.9 7,824 230 81.7 122
July–Dec. 14,920 90.7 8,294 270 77.4 172
1988 Jan.–June 17,436 88.9 9,724 265 70.2 140
July–Dec. 17,907 89.1 11,076 349 71.3 179
1989 Jan.–June 21,071 86.5 12,756 363 70.5 175
July–Dec. 21,382 85.9 14,667 352 71.0 193
1990 Jan.–June 24,464 83.7 15,073 394 66.5 195
July–Dec. 23,802 82.6 16,072 409 60.9 198
1991 Jan.–June 28,608 80.1 17,151 408 62.0 174
July–Dec. 30,710 78.1 19,069 398 57.8 222
1992 Jan.–June 37,604 72.8 19,709 487 56.3 195
July–Dec. 40,513 69.9 20,965 450 57.6 225
1993 Jan.–June 42,664 61.0 21,464 439 53.1 257
July–Dec. 35,500 56.7 22,644 446 53.8 271
1994 Jan.–June 37,132 49.2 23,543 422 49.3 298
July–Dec. 33,299 42.2 24,567 356 45.5 255
1995 Jan.–June 35,324 33.7 24,082 317 33.8 270
July–Dec. 30,290 26.4 23,776 302 27.2 243
1996 Jan.–June 30,125 19.4 20,012 243 22.6 218
July–Dec. 24,112 14.7 14,545 176 14.2 172
1997 Jan.–June 21,255 10.2 10,045 139 15.8 112
July-Dec. 9,731 5.6 4,140 28 7.1 41
Total2 633,000 61.0 385,968 8,086 58.4 4,724
1Persons whose vital status is unknown are included in counts of diagnosed cases, but excluded from counts of deaths.  Case-fatality rates are calcu-
lated for each half-year by date of diagnosis. Each 6-month case-fatality rate is the number of deaths ever reported among cases diagnosed in that
period (regardless of the year of death), divided by the number of total cases diagnosed in that period, multiplied by 100. For example, during the
interval January through June 1982, AIDS was diagnosed in 440 adults/adolescents. Through December 1997, 410 of these 440 were reported as
dead. Therefore, the case fatality rate is 93.2 (410 divided by 440, multiplied by 100). The case-fatality rates shown here may be underestimates
because of incomplete reporting of deaths. Reported deaths are not necessarily caused by HIV-related disease.
2Death totals include 443 adults/adolescents and 7 children known to have died, but whose dates of death are unknown.
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Table 14. Deaths in persons with AIDS, by race/ethnicity, age at death, and sex, occurring in
1995 and 1996; and cumulative totals reported through December 1997, 
United States1
Males Females Both sexes
Race/ethnicity








 Under 15 47 32 532 46 31 398 93 63 930
 15-24 150 78 2,437 52 33 438 202 111 2,875
 25-34 4,904 2,888 51,591 591 404 4,162 5,495 3,292 55,753
 35-44 8,519 5,450 73,682 716 554 4,191 9,235 6,004 77,873
 45-54 4,026 2,621 32,790 261 207 1,603 4,287 2,828 34,393
 55 or older 1,441 918 13,801 122 104 1,537 1,563 1,022 15,338
 All ages 19,087 11,987 175,018 1,788 1,333 12,354 20,875 13,320 187,372
Black, not Hispanic
 Under 15 143 125 1,314 138 110 1,289 281 235 2,603
 15-24 198 125 2,247 176 113 1,213 374 238 3,460
 25-34 3,408 2,535 30,321 1,360 1,098 10,014 4,768 3,633 40,335
 35-44 6,087 4,769 43,038 1,869 1,711 11,942 7,956 6,480 54,980
 45-54 2,803 2,408 17,677 665 652 3,809 3,468 3,060 21,486
 55 or older 1,097 1,009 7,490 309 238 1,717 1,406 1,247 9,207
 All ages 13,736 10,971 102,198 4,517 3,922 30,023 18,253 14,893 132,221
Hispanic
 Under 15 58 43 584 59 39 530 117 82 1,114
 15-24 100 57 1,254 34 39 437 134 96 1,691
 25-34 2,064 1,341 18,577 508 399 3,986 2,572 1,740 22,563
 35-44 3,013 2,163 22,995 667 559 4,085 3,680 2,722 27,080
 45-54 1,280 1,018 8,992 264 208 1,383 1,544 1,226 10,375
 55 or older 519 391 3,650 112 98 665 631 489 4,315
 All ages 7,034 5,013 56,119 1,644 1,342 11,098 8,678 6,355 67,217
Asian/Pacific Islander
 Under 15 2 — 18 3 2 15 5 2 33
 15-24 3 1 32 — — 5 3 1 37
 25-34 73 46 651 8 13 68 81 59 719
 35-44 147 109 1,010 11 10 88 158 119 1,098
 45-54 60 49 480 5 5 53 65 54 533
 55 or older 30 21 214 2 5 39 32 26 253
 All ages 315 226 2,406 29 35 270 344 261 2,676
American Indian/Alaska Native
 Under 15 — 1 11 2 — 8 2 1 19
 15-24 2 3 25 1 — 3 3 3 28
 25-34 55 23 318 8 7 52 63 30 370
 35-44 69 39 322 8 9 45 77 48 367
 45-54 18 10 97 5 4 16 23 14 113
 55 or older 5 1 34 3 — 7 8 1 41
 All ages 149 77 811 27 20 131 176 97 942
All racial/ethnic groups
 Under 15 250 203 2,461 248 182 2,242 498 385 4,703
 15-24 454 264 6,000 263 185 2,098 717 449 8,098
 25-34 10,520 6,837 101,520 2,476 1,922 18,286 12,996 8,759 119,806
 35-44 17,853 12,534 141,155 3,271 2,844 20,359 21,124 15,378 161,514
 45-54 8,195 6,111 60,076 1,201 1,076 6,867 9,396 7,187 66,943
 55 or older 3,092 2,344 25,211 548 445 3,967 3,640 2,789 29,178
 All ages 40,364 28,293 336,795 8,007 6,654 53,897 48,371 34,947 390,692
1Data tabulations for 1995 and 1996 are based on date of death occurrence. Data for deaths occurring in 1997 are incomplete and not tabulated sep-
arately, but are included in the cumulative totals. Tabulations for 1995 and 1996 may increase as additional deaths are reported to CDC.
2Data tabulated under "all ages" include 450 persons whose age at death is unknown. Data tabulated under "all racial/ethnic groups" include 264 per-
sons whose race/ethnicity is unknown.
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Table 15. Adult/adolescent AIDS cases among Hispanics, by exposure category and place of




America Cuba Mexico Puerto Rico Totals2
Adult/adolescent 
exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 1,174 (29) 323 (40) 112 (38) 572 (51) 485 (15) 3,355 (27)
Injecting drug use 1,084 (27) 42 ( 5) 21 ( 7) 77 ( 7) 1,554 (47) 3,645 (29)
Men who have sex with men 
and inject drugs 143 ( 4) 8 ( 1) 11 ( 4) 26 ( 2) 133 ( 4) 367 ( 3)
Heterosexual contact 444 (11) 126 (16) 25 ( 8) 141 (13) 839 (25) 1,950 (16)
Hemophilia/coagulation 
disorder or receipt of 
blood transfusion, blood 
components, or tissue 30 ( 1) 6 ( 1) 4 ( 1) 16 ( 1) 19 ( 1) 86 ( 1)
Risk not reported or identified3 1,184 (29) 296 (37) 124 (42) 285 (26) 267 ( 8) 2,953 (24)
Total 4,059 (100) 801 (100) 297 (100) 1,117 (100) 3,297 (100) 12,356 (100)
1Excludes persons born in U.S. dependencies, possessions, and independent nations in free association with the United States. Ancestry data for
U.S.-born Hispanics are not collected.
2Includes 287 Hispanics born in locations other than those listed, and 2,498 Hispanics whose place of birth is unknown.
3See figure 7.
Table 16. Healthcare workers with documented and possible occupationally acquired AIDS or






Dental worker, including dentist — 7
Embalmer/morgue technician 1 2
Emergency medical technician/paramedic — 12
Health aide/attendant 1 15
Housekeeper/maintenance worker 1 10
Laboratory technician, clinical 16 18
Laboratory technician, nonclinical 3 0
Nurse 22 32
Physician, nonsurgical 6 11
Physician, surgical — 6
Respiratory therapist 1 2
Technician, dialysis 1 3
Technician, surgical 2 2
Technician/therapist, other than those listed above 0 9
Other healthcare occupations — 3
Total 54 132
1Healthcare workers are defined as those persons, including students and trainees, who have worked in a healthcare, clinical, or HIV laboratory
setting at any time since 1978. See MMWR 1992;41:823-25. 
2Healthcare workers who had documented HIV seroconversion after occupational exposure or had other laboratory evidence of occupational infec-
tion: 46 had percutaneous exposure, 5 had mucocutaneous exposure, 2 had both percutaneous and mucocutaneous exposures, and 1 had an
unknown route of exposure. Forty-nine exposures were to blood from an HIV-infected person, 1 to visibly bloody fluid, 1 to an unspecified fluid, and
3 to concentrated virus in a laboratory. Twenty-five of these healthcare workers developed AIDS. 
3These healthcare workers have been investigated and are without identifiable behavioral or transfusion risks; each reported percutaneous or
mucocutaneous occupational exposures to blood or body fluids, or laboratory solutions containing HIV, but HIV seroconversion specifically result-
ing from an occupational exposure was not documented.  Since the previous edition of the Report, a specific review was conducted of AIDS cases
without identifiable behavioral or transfusion risks to identify possible cases related to occupational transmission.  Additional cases of healthcare
workers with AIDS and without behavioral or transfusion risks were found and were added to the possible occupational transmission category.
Most of these cases were diagnosed with AIDS more than 5 years ago; therefore, this does not indicate a recent increase in the trend of possible
occupational transmission.
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Table 17. Adult/adolescent AIDS cases by single and multiple exposure categories, reported
through December 1997, United States
AIDS cases
Exposure category No. (%)
Single mode of exposure
Men who have sex with men 296,483 (47)
Injecting drug use 129,990 (21)
Hemophilia/coagulation disorder 3,784 ( 1)
Heterosexual contact 57,360 ( 9)
Receipt of transfusion1 8,201 ( 1)
Receipt of transplant of tissues, organs, or artificial insemination2 13 ( 0)
Other3 114 ( 0)
Single mode of exposure subtotal 495,945 (78)
Multiple modes of exposure
Men who have sex with men; injecting drug use 34,845 ( 6)
Men who have sex with men; hemophilia/coagulation disorder 155 ( 0)
Men who have sex with men; heterosexual contact 8,966 ( 1)
Men who have sex with men; receipt of transfusion/transplant 3,315 ( 1)
Injecting drug use; hemophilia/coagulation disorder 183 ( 0)
Injecting drug use; heterosexual contact 29,051 ( 5)
Injecting drug use; receipt of transfusion/transplant 1,581 ( 0)
Hemophilia/coagulation disorder; heterosexual contact 86 ( 0)
Hemophilia/coagulation disorder; receipt of transfusion/transplant 785 ( 0)
Heterosexual contact; receipt of transfusion/transplant 1,524 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder 44 ( 0)
Men who have sex with men; injecting drug use; heterosexual contact 4,868 ( 1)
Men who have sex with men; injecting drug use; receipt of transfusion/transplant 587 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact 22 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; receipt of transfusion/transplant 35 ( 0)
Men who have sex with men; heterosexual contact; receipt of transfusion/transplant 266 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact 68 ( 0)
Injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 38 ( 0)
Injecting drug use; heterosexual contact; receipt of transfusion/transplant 938 ( 0)
Hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 34 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact 11 (0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 14 (0)
Men who have sex with men; injecting drug use; heterosexual contact; receipt of transfusion/transplant 160 (0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 5 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 23 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact; 
receipt of transfusion/transplant 5 ( 0)
Multiple modes of exposure subtotal 87,609 (14)
Risk not reported or identified4 49,446 ( 8)
Total 633,000 (100)
1Includes 37 adult/adolescents who developed AIDS after receiving blood screened negative for HIV antibody.
2Thirteen adults developed AIDS after receiving tissue, organs, or artificial insemination from HIV-infected donors. Four of the 13 received tissue or
organs from a single donor who was negative for HIV antibody at the time of donation. See N Engl J Med 1992;326:726-32.
3See table 16 and figure 7 for a discussion of the "other" exposure category. "Other" also includes 82 persons who acquired HIV infection perinatally,
but were diagnosed with AIDS after age 13.
4See figure 7.
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Figure 1. Male adult/adolescent AIDS annual rates per 100,000 population, for cases 
reported in 1997, United States
Figure 2. Female adult/adolescent AIDS annual rates per 100,000 population, for cases 
reported in 1997, United States
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Figure 3. Male/adult adolescent AIDS cases reported in 1997, United States
Figure 4. Female adult/adolescent AIDS cases reported in 1997, United States
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Figure 5. Pediatric AIDS cases reported in 1997, United States




AIDS case reports received
after January 1, 1993, were
influenced by the expanded
AIDS surveillance case definition
and chiefly represent reporting of
persons who had CD4  cell counts
below 200/mL with or without
illness.  This change greatly
altered the pattern of case reports
and was most pronounced in the
first quarter of 1993.
+
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Figure 7. Results of investigations of adult/adolescent AIDS cases ever classified as risk 
not reported or identified, through December 1997, United States1
 
1Excludes 144 children under 13 years of age classified as “other/risk not reported or identified” in table 3; 132 whose risk is not identified, 2 who were
exposed to HIV-infected blood in a household setting, as supported by seroconversion, epidemiologic, and/or laboratory evidence (see MMWR
1992;41:228-31 and N Engl J Med 1993;329:1835-41) and 10 children who had sexual contact with an adult with or at  high risk for HIV infection (Xth
International Conference on AIDS; Yokohama; Japan, Aug. 7-12, 1994;2:258 [abstract PC 0401]).  An additional 429 children who were initially
reported without risk information have been reclassified after investigation.
2Cases associated with persons born in Pattern-II countries are no longer classified as heterosexual transmission. See Technical Notes.
3Investigations of these persons included patient interviews. Based on available information, these persons could not be reclassified into an exposure
category. This group includes persons possibly infected through heterosexual contact with a partner who is not known to be HIV infected or at  risk for
HIV infection; persons who may choose not to disclose high-risk information; and persons with possible occupational exposure. These 959 persons
report heterosexual contact, sexually transmitted disease infections, non-injecting drug use, hepatitis infections, and occupational exposures to blood
or body fluids.
4One hundred fourteen adults/adolescents are included in the “other” exposure category listed here and in table 3, and were exposed to HIV-infected
blood, body fluids, or concentrated virus in health care, laboratory, or household settings, as supported by seroconversion, epidemiologic, and/or lab-
oratory evidence. See table 16, MMWR 1993;42:329-31, MMWR 1993;42:948-51, and XI International Conference on AIDS; Vancouver, Canada; Jul.
7-12, 1996;1:179 [abstract Mo.D.1728]. One person was infected following intentional self-inoculation of blood from an HIV-infected person.  Eighty-
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Table 18. Estimated AIDS-opportunistic illness incidence, by region of residence and year of




1991 1992 1993 1994 1995 1996
Northeast 15,500 17,000 18,000 18,500 19,000 17,500
Midwest 5,400 6,100 6,100 6,200 6,500 5,900
South 17,000 20,000 20,000 21,500 21,500 21,500
West 12,000 12,500 12,000 12,500 12,000 10,500
U.S. dependencies, 
possessions, and 
associated nations 2,075 2,100 2,150 1,950 2,000 1,925
Total3 52,500 57,500 58,000 60,500 61,500 57,500
1Estimates are adjusted for delays in the reporting of AIDS cases, but not for incomplete reporting of cases.  Estimates of less than 1,000, 1,000 to
2,499, 2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to the nearest 10, 25, 50, 100, and 500, respectively.  Opportunistic illness
refers to AIDS-defining opportunistic illnesses included in the 1993 AIDS surveillance case definition.  Annual estimates are through the most recent
year for which reliable estimates are available.  Because there is uncertainty in AIDS-OI incidence, changes over time in AIDS-OI incidence should
not be computed from these rounded estimates.  See Technical Notes.
2See Technical Notes for a list of states or U.S. dependencies, possessions, and associated nations which comprise each region of residence.
3The sum of the regional estimates may not equal the total annual estimates because of rounding.
Table 19. Estimated AIDS-opportunistic illness incidence, by race/ethnicity and year of 
diagnosis, 1991 through 1996, United States1
Year of diagnosis
Race/ethnicity 1991 1992 1993 1994 1995 1996
White, not Hispanic 25,000 26,000 24,500 25,000 24,500 21,000
Black, not Hispanic 17,500 20,500 22,000 23,500 24,500 24,500
Hispanic 9,400 10,500 11,000 11,000 11,500 11,000
Asian/Pacific 
Islander 360 420 420 460 470 480
American Indian/
Alaska Native 140 160 170 200 200 190
Total2 52,500 57,500 58,000 60,500 61,500 57,500
1Estimates are adjusted for delays in the reporting of AIDS cases, but not for incomplete reporting of cases.  Estimates of less than 1,000, 1,000 to
2,499, 2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to the nearest 10, 25, 50, 100, and 500, respectively.   Opportunistic illness
refers to AIDS-defining opportunistic illnesses included in the 1993 AIDS surveillance case definition.  Annual estimates are through the most recent
year for which reliable estimates are available.  Because there is uncertainty in AIDS-OI incidence, changes over time in AIDS-OI incidence should
not be computed from these rounded estimates.  See Technical Notes.
2Totals include estimates of persons whose race/ethnicity is unknown.
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Table 20. Estimated AIDS-opportunistic illness incidence, by age group, sex, exposure 




1991 1992 1993 1994 1995 1996
Men who have sex with men 28,000 29,000 28,000 29,000 28,500 25,500
Injecting drug use 10,000 12,000 12,500 13,000 13,000 12,500
Men who have sex with men
and inject drugs 3,650 3,950 3,650 3,700 3,650 3,100
Hemophilia/coagulation disorder 400 450 430 410 380 290
Heterosexual contact 1,525 2,100 2,550 2,950 3,450 3,750
Reciept of blood transfusion,
blood components, or tissue 420 390 320 340 320 320
Risk not reported or identified 330 350 270 130 140 120
Male sutotal 44,500 48,000 48,000 49,500 49,500 45,500
Female adult/adolescent
exposure category
Injecting drug use 3,700 4,350 4,600 4,800 4,950 4,800
Hemophilia/coagulation disorder 20 20 20 30 40 40
Heterosexual contact 2,850 3,650 4,400 5,100 5,800 6,200
Reciept of blood transfusion,
blood components, or tissue 300 290 270 300 290 290
Risk not reported or identified 160 150 100 70 60 60
Female subtotal 7,000 8,500 9,400 10,500 11,000 11,500
Pediatric (<13 years old)
exposure category2 810 940 890 800 670 490
Total3 52,500 57,500 58,000 60,500 61,500 57,500
1Estimates are adjusted for delays in the reporting of AIDS cases and anticipated redistribution of cases initially reported with no identified risk, but not
for incomplete reporting of cases.  Estimates of less than 1,000, 1,000 to 2,499, 2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to
the nearest 10, 25, 50, 100, and 500, respectively.    Opportunistic illness refers to AIDS-defining opportunistic illnesses included in the 1993 AIDS
surveillance case definition.  Annual estimates are through the most recent year for which reliable estimates are available.  Because there is uncer-
tainty in AIDS-OI incidence, changes over time in AIDS-OI incidence should not be computed from these rounded estimates.  See Technical Notes.
2Estimates are based on cases diagnosed using the 1987 definition, adjusted for reporting delays.  The 1993 AIDS surveillance case definition
affected only adult/adolescent cases, not pediatric cases.
3The sum of the exposure category estimates may not equal the subtotal and total annual estimates because of rounding.
Table 21. Estimated deaths of persons with AIDS, by region of residence and year of death,
1991 through 1996, United States1
Region of residence2
Year of death
1991 1992 1993 1994 1995 1996
Northeast 11,500 13,000 14,000 15,500 15,500 11,500
Midwest 3,500 4,200 4,750 5,200 5,500 4,100
South 11,500 13,000 14,500 16,000 17,000 14,000
West 8,800 9,600 10,500 10,500 10,000 6,600
U.S. dependencies, 
possessions, and 
associated nations 1,325 1,375 1,550 1,750 1,700 1,600
Total3 36,500 41,000 45,000 49,500 50,000 37,500
1Estimates are adjusted for delays in the reporting of deaths, but not for incomplete reporting of deaths.  Estimates of less than 1,000, 1,000 to 2,499,
2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to the nearest 10, 25, 50, 100, and 500, respectively.   Annual estimates are through
the most recent year for which reliable estimates are available.  Because there is uncertainty in the estimates of deaths of persons with AIDS,
changes over time in the estimates of deaths of persons with AIDS should not be computed from these rounded estimates.  See Technical Notes.
2See Technical Notes for a list of states or U.S. dependencies, possessions, and asociated nations which comprise each region of residence.
3The sum of the regional estimates may not equal the total annual estimates because of rounding.
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Table 22. Estimated deaths of persons with AIDS, by race/ethnicity and year of death, 1991
through 1996, United States1
Year of death
Race/ethnicity 1991 1992 1993 1994 1995 1996
White, not Hispanic 19,000 20,500 21,500 22,000 21,500 14,500
Black, not Hispanic 11,000 13,500 15,500 17,500 19,000 16,000
Hispanic 6,300 7,100 7,700 8,800 9,000 6,900
Asian/Pacific 
Islander 250 270 300 400 350 280
American Indian/
Alaska Native 90 80 130 140 180 100
Total2 36,500 41,000 45,000 49,500 50,000 37,500
1Estimates are adjusted for delays in the reporting of deaths, but not for incomplete reporting of deaths.  Estimates of less than 1,000, 1,000 to 2,499,
2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to the nearest 10, 25, 50, 100, and 500, respectively.   Annual estimates are through
the most recent year for which reliable estimates are available.  Because there is uncertainty in the estimates of deaths of persons with AIDS,
changes over time in the estimates of deaths of persons with AIDS should not be computed from these rounded estimates.  See Technical Notes.
2Totals include estimates of persons whose race/ethnicity is unknown.
Table 23. Estimated deaths of persons with AIDS, by age group, sex, exposure category,




1991 1992 1993 1994 1995 1996
Men who have sex with men 21,000 23,000 23,500 25,000 24,500 16,500
Injecting drug use 6,900 8,100 9,200 10,500 10,500 8,500
Men who have sex with men
and inject drugs 2,450 2,700 3,000 3,300 3,250 2,425
Hemophilia/coagulation disorder 280 320 350 340 320 220
Heterosexual contact 830 1,175 1,550 1,925 2,300 2,050
Reciept of blood transfusion,
blood components, or tissue 370 330 320 300 270 230
Risk not reported or identified 210 240 200 160 120 70
Male sutotal 32,000 35,500 38,500 41,500 41,500 30,000
Female adult/adolescent
exposure category
Injecting drug use 2,250 2,700 3,100 3,650 3,750 3,250
Hemophilia/coagulation disorder 10 20 20 20 30 20
Heterosexual contact 1,625 1,975 2,600 3,450 3,900 3,450
Reciept of blood transfusion,
blood components, or tissue 250 250 240 240 240 180
Risk not reported or identified 80 110 90 70 60 40
Female subtotal 4,250 5,100 6,000 7,400 8,000 7,000
Pediatric (<13 years old)
exposure category 400 420 530 560 530 420
Total2 36,500 41,000 45,000 49,500 50,000 37,500
1Estimates are adjusted for delays in the reporting of deaths, but not for incomplete reporting of deaths.  Estimates of less than 1,000, 1,000 to 2,499,
2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to the nearest 10, 25, 50, 100, and 500, respectively.   Annual estimates are through
the most recent year for which reliable estimates are available.  Because there is uncertainty in the estimates of deaths of persons with AIDS,
changes over time in the estimates of deaths of persons with AIDS should not be computed from these rounded estimates.  See Technical Notes.
2The sum of the exposure category estimates may not equal the total annual estimates because of rounding.
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1991 1992 1993 1994 1995 1996
Northeast 29,000 39,500 51,500 59,000 65,500 73,000
Midwest 11,000 15,000 18,500 20,500 22,000 24,000
South 33,500 47,000 59,500 69,000 76,500 87,000
West 24,500 33,000 39,000 42,500 46,000 50,500
U.S. dependencies, 
possessions, and 
associated nations 3,500 4,650 5,800 6,400 6,800 7,400
Total3 101,500 139,500 174,000 197,500 217,000 242,000
1Estimates of persons living with AIDS are derived by subtracting the estimated cumulative number of deaths in persons with AIDS from the estimated
cumulative number of persons with AIDS.  Estimated AIDS cases and estimated deaths are adjusted for reporting delays, but not for incomplete
reporting.  Estimates of less than 1,000, 1,000 to 2,499, 2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to the nearest 10, 25, 50,
100, and 500, respectively.   Annual estimates are through the most recent year for which reliable estimates are available.  Because there is uncer-
tainty in the estimates of persons living with AIDS, changes over time in the estimates of persons living with AIDS should not be computed from these
rounded estimates.  See Technical Notes.
2See Technical Notes for a list of states or U.S. dependencies, possessions, and associated nations which comprise each region of residence.
3The sum of the regional estimates may not equal the total annual estimates because of rounding.




1991 1992 1993 1994 1995 1996
White, not Hispanic 52,000 68,500 80,500 86,500 92,000 99,000
Black, not Hispanic 31,500 45,500 60,500 72,000 81,500 93,000
Hispanic 17,000 23,500 31,000 36,500 41,000 46,500
Asian/Pacific 
Islander 690 1,000 1,275 1,450 1,600 1,875
American Indian/
Alaska Native 280 450 540 640 700 800
Total2 101,500 139,500 174,000 197,500 217,000 242,000
1Estimates of persons living with AIDS are derived by subtracting the estimated cumulative number of deaths in persons with AIDS from the estimated
cumulative number of persons with AIDS.  Estimated AIDS cases and estimated deaths are adjusted for reporting delays, but not for incomplete
reporting.  Estimates of less than 1,000, 1,000 to 2,499, 2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to the nearest 10, 25, 50,
100, and 500, respectively.    Annual estimates are through the most recent year for which reliable estimates are available.  See Technical Notes.
2Totals include estimates of persons whose race/ethnicity is unknown.
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Table 26. Estimated persons living with AIDS, by age group, sex, exposure category, 




1991 1992 1993 1994 1995 1996
Men who have sex with men 55,500 73,000 87,000 95,500 102,500 112,500
Injecting drug use 18,000 26,000 34,500 40,000 44,500 49,500
Men who have sex with men
and inject drugs 8,200 11,000 13,000 14,000 14,500 15,000
Hemophilia/coagulation disorder 980 1,425 1,600 1,675 1,700 1,700
Heterosexual contact 2,425 4,050 6,100 7,900 9,800 12,500
Reciept of blood transfusion,
blood components, or tissue 700 860 960 1,025 1,125 1,225
Risk not reported or identified 900 1,100 1,200 1,175 1,175 1,250
Male sutotal 87,000 117,500 144,500 161,500 175,500 193,500
Female adult/adolescent
exposure category
Injecting drug use 6,900 10,000 13,500 16,000 18,000 20,000
Hemophilia/coagulation disorder 50 60 80 100 130 150
Heterosexual contact 4,750 8,000 12,000 15,000 18,500 22,500
Reciept of blood transfusion,
blood components, or tissue 540 680 820 920 1,000 1150
Risk not reported or identified 330 420 450 450 460 500
Female subtotal 12,500 19,500 27,000 32,500 38,000 44,500
Pediatric (<13 years old)
exposure category 2,125 2,650 3,000 3,250 3,350 3,450
Total2 101,500 139,500 174,000 197,500 217,000 242,000
1Estimates of persons living with AIDS are derived by subtracting the estimated cumulative number of deaths in persons with AIDS from the estimated
cumulative number of persons with AIDS.  Estimated AIDS cases and estimated deaths are adjusted for reporting delays, but not for incomplete
reporting.  Estimates of less than 1,000, 1,000 to 2,499, 2,500 to 4,999, 5,000 to 9,999, and 10,000 or more are rounded to the nearest 10, 25, 50,
100, and 500, respectively.   Annual estimates are through the most recent year for which reliable estimates are available.  Because there is uncer-
tainty in the estimates of persons living with AIDS, changes over time in the estimates of persons living with AIDS should not be computed from these
rounded estimates.  See Technical Notes.
2The sum of exposure category estimates may not equal the total annual estimates because of rounding.
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Table 27. HIV infection cases1 by state, reported in 1996 and 1997; and cumulative totals, by
state and age group, through December 1997, from states with confidential HIV 
infection reporting
Cumulative totals
State of residence 




<13 years old Total
Alabama (Jan. 1988) 490 529 4,381 36 4,417
Arizona (Jan. 1987) 334 343 3,631 38 3,669
Arkansas (July 1989) 204 208 1,578 18 1,596
Colorado (Nov. 1985) 413 358 5,205 27 5,232
Connecticut (July 1992)3 13 5 — 96 96
Florida (July 1997) 35 1,948 2,086 20 2,106
Idaho (June 1986) 32 28 293 2 295
Indiana (July 1988) 373 484 3,035 28 3,063
Louisiana (Feb. 1993) 1,233 1,091 5,463 99 5,562
Michigan (April 1992) 774 820 4,202 100 4,302
Minnesota (Oct. 1985) 234 221 2,241 25 2,266
Mississippi (Aug. 1988) 512 529 3,646 39 3,685
Missouri (Oct. 1987) 526 494 3,711 40 3,751
Nebraska (Sept. 1995) 150 93 346 5 351
Nevada (Feb. 1992) 431 356 2,403 21 2,424
New Jersey (Jan. 1992) 1,960 1,940 11,914 353 12,267
North Carolina (Feb. 1990) 994 1,111 7,758 99 7,857
North Dakota (Jan. 1988) 7 6 62 62
Ohio (June 1990) 654 447 3,791 55 3,846
Oklahoma (June 1988) 206 219 1,858 14 1,872
Oregon (Sept. 1988)3 3 8 — 11 11
South Carolina (Feb. 1986) 688 718 6,161 106 6,267
South Dakota (Jan. 1988) 11 17 175 5 180
Tennessee (Jan. 1992) 732 866 4,419 43 4,462
Texas (Feb. 1994)3 14 39 — 225 225
Utah (April 1989) 101 84 780 4 784
Virginia (July 1989) 864 930 6,859 76 6,935
West Virginia (Jan. 1989) 65 69 451 1 452
Wisconsin (Nov. 1985) 215 224 2,077 30 2,107
Wyoming (June 1989) 8 8 60 — 60
Subtotal 12,276 14,193 88,586 1,616 90,202
Other/unknown4 262 322 1,854 51 1,905
Total 12,538 14,515 90,440 1,667 92,107
1Includes only persons reported with HIV infection who have not developed AIDS.
2Persons reported prior to the date their state of residence initiated HIV reporting were reported from another state with confidential HIV infection
reporting.
3Connecticut and Texas have confidential HIV infection reporting for pediatric cases only; Oregon has confidential reporting for children less han 6
years old.
4Includes persons reported from states with confidential HIV reporting who were residents of states without confidential HIV infection reporting and
295 persons whose state of residence is unknown.  See Technical Notes.
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Table 28. Male adult/adolescent HIV infection cases1 by exposure category and
race/ethnicity, reported in 1997, and cumulative totals through December 1997,
from states with confidential HIV infection reporting2








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 2,286 (59) 18,296 (61) 1,342 (27) 10,002 (32) 274 (35) 1,489 (35)
Injecting drug use 351 ( 9) 2,710 ( 9) 740 (15) 6,470 (21) 132 (17) 1,113 (26)
Men who have sex with men and 
inject drugs 242 ( 6) 2,480 ( 8) 146 ( 3) 1,581 ( 5) 18 ( 2) 246 ( 6)
Hemophilia/coagulation disorder 19 ( 0) 319 ( 1) 9 ( 0) 77 ( 0) 1 ( 0) 9 ( 0)
Heterosexual contact: 126 ( 3) 771 ( 3) 492 (10) 2,875 ( 9) 55 ( 7) 253 ( 6)
Sex with an injecting drug user 26 207 98 704 16 83
Sex with person with hemophilia — 3 1 8 — —
Sex with transfusion recipient 
with HIV infection 2 17 7 46 — 2
Sex with HIV-infected person, 
risk not specified 98 544 386 2,117 39 168
Receipt of blood tranfusion, 
blood components, or tissue 10 ( 0) 170 ( 1) 12 ( 0) 152 ( 0) 3 ( 0) 25 ( 1)
Risk not reported or identified3 845 (22) 5,207 (17) 2,201 (45) 10,331 (33) 309 (39) 1,076 (26)
Total 3,879 (100) 29,953 (100) 4,942 (100) 31,488 (100) 792 (100) 4,211 (100)








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 16 (42) 95 (48) 29 (47) 189 (48) 3,985 (40) 30,315 (45)
Injecting drug use 1 16 ( 8) 8 (13) 58 (15) 1,242 (13) 10,432 (15)
Men who have sex with men and 
inject drugs — 3 ( 2) 7 (11) 58 (15) 419 ( 4) 4,393 ( 7)
Hemophilia/coagulation disorder 1 2 ( 1) — — 2 ( 1) 30 ( 0) 413 ( 1)
Heterosexual contact: 3 11 ( 6) 1 ( 2) 19 ( 5) 680 ( 7) 3,945 ( 6)
Sex with an injecting drug user 1 5 1 8 142 1,010
Sex with person with hemophilia — — — — 1 11
Sex with transfusion recipient 
with HIV infection — — — — 10 66
Sex with HIV-infected person, 
risk not specified 2 6 — 11 527 2,858
Receipt of blood tranfusion, 
blood components, or tissue — 1 ( 1) — — 2 ( 1) 25 ( 0) 355 ( 1)
Risk not reported or identified 17 (45) 70 (35) 17 (27) 62 (16) 3,513 (36) 17,519 (26)
Total 38 (100) 198 (100) 62 (100) 390 (100) 9,894 (100) 67,372 (100)
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 27 for states with confidential HIV infection reporting.
3For HIV infection cases, "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who have not been
followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
4Includes1,132 men whose race/ethnicity is unknown.
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Table 29. Female adult/adolescent HIV infection cases1 by exposure category and
race/ethnicity, reported in 1997, and cumulative totals, through December 1997,
from states with confidential HIV infection reporting2








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use 204 (21) 1,629 (29) 386 (13) 3,370 (22) 57 (19) 368 (26)
Hemophilia/coagulation disorder 1 ( 0) 10 ( 0) 2 ( 0) 10 ( 0) — — — —
Heterosexual contact: 375 (39) 2,310 (41) 992 (33) 5,767 (37) 112 (37) 573 (41)
Sex with an injecting drug user 104 838 229 1,722 35 240
Sex with a bisexual male 36 271 75 434 4 22
Sex with person with hemophilia 5 58 3 29 1 7
Sex with transfusion recipient 
with HIV infection 3 28 7 42 2 5
Sex with HIV-infected person, 
risk not specified 227 1,115 678 3,540 70 299
Receipt of blood tranfusion, 
blood components, or tissue 12 ( 1) 119 ( 2) 21 ( 1) 218 ( 1) 2 ( 1) 20 ( 1)
Risk not reported or identified3 362 (38) 1,620 (28) 1,615 (54) 6,122 (40) 134 (44) 438 (31)
Total 954 (100) 5,688 (100) 3,016 (100) 15,487 (100) 305 (100) 1,399 (100)








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use 1 ( 7) 7 (10) 9 (43) 54 (38) 663 (15) 5,455 (24)
Hemophilia/coagulation disorder — — — — — — — — 3 ( 0) 20 ( 0)
Heterosexual contact: 4 (29) 26 (36) 5 (24) 54 (38) 1,491 (34) 8,764 (38)
Sex with an injecting drug user — 6 4 32 373 2,846
Sex with a bisexual male — 1 — 7 115 739
Sex with person with hemophilia — — — — 9 94
Sex with transfusion recipient 
with HIV infection — — — — 12 75
Sex with HIV-infected person, 
risk not specified 4 19 1 15 982 5,010
Receipt of blood tranfusion, 
blood components, or tissue — — 1 ( 1) — — 1 ( 1) 35 ( 1) 361 ( 2)
Risk not reported or identified 9 (64) 38 (53) 7 (33) 34 (24) 2,170 (50) 8,458 (37)
Total 14 (100) 72 (100) 21 (100) 143 (100) 4,362 (100) 23,058 (100)
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 27 for states with confidential HIV infection reporting.
3For HIV infection cases, "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who have not been
followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
4Includes 269 women whose race/ethnicity is unknown.
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Table 30. Pediatric HIV infection cases1 by exposure category and race/ethnicity, reported in
1997, and cumulative totals through December 1997, from states with confidential
HIV infection reporting2








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hemophilia/coagulation disorder 3 ( 7) 68 (17) — — 20 ( 2) 1 ( 4) 6 ( 3)
Mother with/at risk for HIV infection: 39 (85) 299 (74) 159 (89) 949 (91) 21 (84) 160 (87)
Injecting drug use 17 94 47 314 2 41
Sex with injecting drug user 7 58 20 116 3 30
Sex with bisexual male 1 4 2 15 — 2
Sex with person with hemophilia — 3 — 2 — —
Sex with transfusion recipient 
with HIV infection — 4 — 3 — —
Sex with HIV-infected person, 
risk not specified 5 57 43 184 7 31
Receipt of blood transfusion, 
blood components, or tissue 1 6 — 10 1 2
Has HIV infection, risk not specified 8 73 47 305 8 54
Receipt of blood transfusion, blood 
components, or tissue — — 18 ( 4) — — 9 ( 1) — — 4 ( 2)
Risk not reported or identified3 4 ( 9) 21 ( 5) 19 (11) 66 ( 6) 3 (12) 14 ( 8)
Total 46 (100) 406 (100) 178 (100) 1,044 (100) 25 (100) 184 (100)
Asian/Pacific Islander
American Indian/








Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hemophilia/coagulation disorder — — 1 (13) — — 1 ( 9) 4 ( 2) 97 ( 6)
Mother with/at risk for HIV infection: 2 (100) 4 (50) 1 (100) 8 (73) 225 (87) 1,428 (86)
Injecting drug use — 1 — 3 67 456
Sex with injecting drug user — — — 2 31 207
Sex with bisexual male 1 2 — — 4 24
Sex with person with hemophilia — — — 1 — 6
Sex with transfusion recipient 
with HIV infection — — — — — 7
Sex with HIV-infected person, 
risk not specified — — — — 55 272
Receipt of blood transfusion, 
blood components, or tissue — — — — 2 18
Has HIV infection, risk not specified 1 1 1 2 66 438
Receipt of blood transfusion, blood
components, or tissue — — 1 (13) — — — — — — 32 ( 2)
Risk not reported or identified — — 2 (25) — — 2 (18) 29 (11) 110 ( 7)
Total 2 (100) 8 (100) 1 (100) 11 (100) 258 (100) 1,667 (100)
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 27 for states with confidential HIV infection reporting.
3For HIV infection cases, "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who have not been
followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
4Includes 14 children whose race/ethnicity is unknown.
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Table 31. HIV infection cases1 in adolescents and adults under age 25, by sex and exposure
category, reported in 1997, and cumulative totals through December 1997, from
states with confidential HIV infection reporting2






Male exposure category No. (%) No. (%) No. (%) No. (%) 
Men who have sex with men 101 (47) 777 (46) 501 (53) 5,016 (55)
Injecting drug use 12 ( 6) 91 ( 5) 34 ( 4) 530 ( 6)
Men who have sex with men 
and inject drugs 6 ( 3) 90
( 5)
40 ( 4) 602 ( 7)
Hemophilia/coagulation disorder 9 ( 4) 99 ( 6) 6 ( 1) 85 ( 1)
Heterosexual contact: 17 ( 8) 114 ( 7) 47 ( 5) 518 ( 6)
Sex with injecting drug user 1 21 6 90
Sex with person with hemophilia 1 2 — 1
Sex with transfusion recipient 
with HIV infection — 1 1 6
Sex with HIV-infected person, 
risk not specified 15 90 40 421
Receipt of blood transfusion,
blood components, or tissue — — 9 ( 1) 4 ( 0) 35 ( 0)
Risk not reported or identified3 68 (32) 492 (29) 312 (33) 2,338 (26)
Male subtotal 213 (100) 1,672 (100) 944 (100) 9,124 (100)
Female exposure category 
Injecting drug use 15 ( 4) 136 ( 7) 42 ( 6) 561 (14)
Hemophilia/coagulation disorder — — — — — — 2 ( 0)
Heterosexual contact: 136 (36) 879 (46) 245 (37) 1,775 (44)
Sex with injecting drug user 15 198 46 496
Sex with bisexual male 9 65 23 171
Sex with person with hemophilia 3 16 3 31
Sex with transfusion recipient 
with HIV infection 1 5 1 16
Sex with HIV-infected person, 
risk not specified 108 595 172 1,061
Receipt of blood transfusion, 
blood components, or tissue 2 ( 1) 14 ( 1) 3 ( 0) 31 ( 1)
Risk not reported or identified 220 (59) 873 (46) 371 (56) 1,700 (42)
Female subtotal 373 (100) 1,902 (100) 661 (100) 4,069 (100)
Total4 586 3,575 1,605 13,194
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 27 for states with confidential HIV infection reporting.
3For HIV infection cases, "risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who have not been
followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
4Includes 2 persons whose sex is unknown.
Vol. 9, No. 2 37 HIV/AIDS Surveillance Report
Table 32. HIV infection cases1 by sex, age at diagnosis, and race/ethnicity, reported 
through December 1997, from states with confidential HIV infection reporting2
Male









No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Under 5 139 ( 0) 426 ( 1) 70 ( 2) 2 ( 1) 2 ( 1) 640 ( 1)
5–12 86 ( 0) 80 ( 0) 26 ( 1) 1 ( 0) 1 ( 0) 198 ( 0)
13–19 618 ( 2) 947 ( 3) 69 ( 2) 6 ( 3) 10 ( 3) 1,672 ( 2)
20–24 4,201 (14) 4,175 (13) 519 (12) 29 (14) 75 (19) 9,124 (13)
25–29 7,361 (24) 6,275 (20) 1,034 (24) 51 (25) 104 (26) 15,067 (22)
30–34 7,284 (24) 7,005 (22) 1,055 (24) 48 (24) 86 (22) 15,750 (23)
35–39 4,890 (16) 5,818 (18) 763 (18) 28 (14) 60 (15) 11,758 (17)
40–44 2,805 ( 9) 3,797 (12) 439 (10) 18 ( 9) 30 ( 8) 7,214 (11)
45–49 1,423 ( 5) 1,822 ( 6) 176 ( 4) 11 ( 5) 12 ( 3) 3,519 ( 5)
50–54 737 ( 2) 858 ( 3) 72 ( 2) 4 ( 2) 6 ( 2) 1,712 ( 3)
55–59 311 ( 1) 400 ( 1) 41 ( 1) – – 4 ( 1) 768 ( 1)
60–64 170 ( 1) 214 ( 1) 24 ( 1) 1 ( 0) 3 ( 1) 423 ( 1)
65 or older 153 ( 1) 177 ( 1) 19 ( 0) 2 ( 1) – – 365 ( 1)
Male subtotal 30,178 (100) 31,994 (100) 4,307 (100) 201 (100) 393 (100) 68,210 (100)
Female
Age at diagnosis (years)
Under 5 144 ( 2) 440 ( 3) 69 ( 5) 4 ( 5) 7 ( 5) 672 ( 3)
5–12 37 ( 1) 98 ( 1) 19 ( 1) 1 ( 1) 1 ( 1) 157 ( 1)
13–19 400 ( 7) 1,381 ( 9) 87 ( 6) 4 ( 5) 16 (11) 1,902 ( 8)
20–24 1,075 (18) 2,697 (17) 215 (14) 19 (25) 27 (18) 4,069 (17)
25–29 1,276 (22) 3,264 (20) 335 (23) 17 (22) 23 (15) 4,972 (21)
30–34 1,231 (21) 3,172 (20) 338 (23) 15 (19) 28 (19) 4,852 (20)
35–39 824 (14) 2,382 (15) 203 (14) 9 (12) 25 (17) 3,484 (15)
40–44 397 ( 7) 1,406 ( 9) 113 ( 8) 4 ( 5) 17 (11) 1,966 ( 8)
45–49 246 ( 4) 606 ( 4) 58 ( 4) 2 ( 3) 5 ( 3) 929 ( 4)
50–54 94 ( 2) 274 ( 2) 24 ( 2) 1 ( 1) 2 ( 1) 398 ( 2)
55–59 52 ( 1) 153 ( 1) 17 ( 1) 1 ( 1) – – 225 ( 1)
60–64 33 ( 1) 69 ( 0) 5 ( 0) – – – – 107 ( 0)
65 or older 60 ( 1) 83 ( 1) 4 ( 0) – – – – 154 ( 1)
Female subtotal 5,869 (100) 16,025 (100) 1,487 (100) 77 (100) 151 (100) 23,887 (100)
Total4 36,047 48,021 5,794 278 544 92,107
1Includes only persons reported with HIV infection who have not developed AIDS.
2See table 27 for states with confidential HIV infection reporting.
3Includes 1,137 males, 278 females, and 8 persons with unknown sex whose race/ethnicity is unknown.
4Includes10 persons whose sex is unknown.
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Table 33. Persons reported to be living with HIV infection1 and with AIDS, by state and age
group, reported through December 19972
U.S. state of residence 
(Date HIV reporting 
initiated)












<13 years old Total
Alabama (Jan. 1988) 4,221 35 4,256 2,211 21 2,232 6,432 56 6,488
Alaska — — — 202 2 204 202 2 204
Arizona (Jan. 1987) 3,260 35 3,295 1,941 6 1,947 5,201 41 5,242
Arkansas (July 1989) 1,556 18 1,574 1,173 20 1,193 2,729 38 2,767
California — — — 36,483 200 36,683 36,483 200 36,683
Colorado (Nov. 1985) 5,016 26 5,042 2,441 7 2,448 7,457 33 7,490
Connecticut (July 1992)5 — 88 88 4,754 80 4,834 4,754 168 4,922
Delaware — — — 904 8 912 904 8 912
District of Columbia — — — 4,375 86 4,461 4,375 86 4,461
Florida (July 1997) 2,049 19 2,068 26,939 573 27,512 28,988 592 29,580
Georgia — — — 8,067 77 8,144 8,067 77 8,144
Hawaii — — — 716 4 720 716 4 720
Idaho (June 1986) 243 2 245 175 — 175 418 2 420
Illinois — — — 7,217 111 7,328 7,217 111 7,328
Indiana (July 1988) 2,934 27 2,961 2,107 14 2,121 5,041 41 5,082
Iowa — — — 457 4 461 457 4 461
Kansas — — — 746 3 749 746 3 749
Kentucky — — — 1,082 11 1,093 1,082 11 1,093
Louisiana (Feb. 1993) 5,218 90 5,308 4,173 53 4,226 9,391 143 9,534
Maine — — — 348 8 356 348 8 356
Maryland — — — 7,086 148 7,234 7,086 148 7,234
Massachussets — — — 4,288 78 4,366 4,288 78 4,366
Michigan (April 1992) 3,520 83 3,603 3,558 31 3,589 7,078 114 7,192
Minnesota (Oct. 1985) 2,116 22 2,138 1,277 11 1,288 3,393 33 3,426
Mississippi (Aug. 1988) 3,524 39 3,563 1,321 23 1,344 4,845 62 4,907
Missouri (Oct. 1987) 3,587 39 3,626 3,406 18 3,424 6,993 57 7,050
Montana — — — 131 — 131 131 — 131
Nebraska (Sept. 1995) 330 5 335 348 4 352 678 9 687
Nevada (Feb. 1992) 2,197 20 2,217 1,791 13 1,804 3,988 33 4,021
New Hampshire — — — 412 3 415 412 3 415
New Jersey (Jan. 1992) 10,765 340 11,105 12,161 249 12,410 22,926 589 23,515
New Mexico — — — 656 3 659 656 3 659
New York — — — 41,346 754 42,100 41,346 754 42,100
North Carolina (Feb. 1990) 7,172 93 7,265 3,097 51 3,148 10,269 144 10,413
North Dakota (Jan. 1988) 55 — 55 36 — 36 91 — 91
Ohio (June 1990) 3,411 53 3,464 3,296 38 3,334 6,707 91 6,798
Oklahoma (June 1988) 1,773 13 1,786 1,296 10 1,306 3,069 23 3,092
Oregon (Sept. 1988)5 — 11 11 1,664 7 1,671 1,664 18 1,682
Pennsylvania — — — 7,676 138 7,814 7,676 138 7,814
Rhode Island — — — 734 4 738 734 4 738
South Carolina (Feb. 1986) 5,885 104 5,989 3,203 26 3,229 9,088 130 9,218
South Dakota (Jan. 1988) 158 5 163 46 1 47 204 6 210
Tennessee (Jan. 1992) 4,292 43 4,335 3,001 18 3,019 7,293 61 7,354
Texas (Feb. 1994)5 — 213 213 18,345 134 18,479 18,345 347 18,692
Utah (April 1989) 767 4 771 668 7 675 1,435 11 1,446
Vermont — — — 144 1 145 144 1 145
Virginia (July 1989) 6,404 73 6,477 4,048 82 4,130 10,452 155 10,607
Washington — — — 3,294 14 3,308 3,294 14 3,308
West Virginia (Jan. 1989) 420 1 421 389 3 392 809 4 813
Wisconsin (Nov. 1985) 1,955 29 1,984 1,297 10 1,307 3,252 39 3,291
Wyoming (June 1989) 56 — 56 60 2 62 116 2 118
Subtotal 82,884 1,530 84,414 236,586 3,169 239,755 319,470 4,699 324,169
U.S. dependencies, possessions, and associated nations
Guam — — — 7 — 7 7 — 7
Pacific Islands, U.S. — — — 2 — 2 2 — 2
Puerto Rico — — — 7,228 169 7,397 7,228 169 7,397
Virgin Islands, U.S. — — — 180 8 188 180 8 188
Total 82,884 1,530 84,414 244,224 3,347 247,571 327,108 4,877 331,985
1Includes only persons reported with HIV infection who have not developed AIDS.
2Persons reported with vital status "alive" as of the last update. Excludes persons whose vital status is unknown.
3Includes only persons reported from states with confidential HIV reporting. Excludes 1,719 adults/adolescents and 47 children reported from states with confidential HIV
infection reporting whose state of residence is unknown or are residents of other states.
4Includes 221 adults/adolescents and 1 child whose state of residence is unknown.
5Connecticut and Texas have confidential HIV infection reporting for pediatric cases only; Oregon has confidential infection reporting for children less than 6 years old.
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Technical Notes
Surveillance of AIDS 
All 50 states, the District of Columbia, U.S. depen-
dencies and possessions, and independent nations in
free association with the United States1 report AIDS
cases to CDC using a uniform surveillance case defi-
nition and case report form. The original definition was
modified in 1985 (MMWR 1985;34:373-75) and 1987
(MMWR 1987;36[suppl no. 1S]:1S-15S). The case
definition for adults and adolescents was modified
again in 1993 (MMWR 1992;41[no. RR-17]:1-19; see
also MMWR 1995;44:64-67). The revisions incorpo-
rated a broader range of AIDS-indicator diseases and
conditions and used HIV diagnostic tests to improve
the sensitivity and specificity of the definition. The lab-
oratory and diagnostic criteria for the 1987 pediatric
case definition (MMWR 1987;36:225-30, 235) were
updated in 1994 (MMWR  1994;43[no. RR-12]: 1-19).
For persons with laboratory-confirmed HIV infec-
tion, the 1987 revision incorporated HIV encephalop-
athy, wasting syndrome, and other indicator diseases
that are diagnosed presumptively (i.e., without confir-
matory laboratory evidence of the opportunistic dis-
ease). In addition to the 23 clinical conditions in the
1987 definition, the 1993 case definition for adults and
adolescents includes HIV-infected persons with CD4+
T-lymphocyte counts of less than 200 cells/µL or a
CD4+ percentage of less than 14, and persons diag-
nosed with pulmonary tuberculosis, recurrent pneu-
monia, and invasive cervical cancer. All conditions
added to the 1993 definition require laboratory confir-
mation of HIV infection. Persons who meet the criteria
for more than one definition category are classified hi-
erarchically in the following order: pre-1987, 1987,
and 1993. Persons in the 1993 definition category
meet only the 1993 definition. 
The pediatric case definition incorporates the re-
vised 1994 pediatric classification system for evi-
dence of HIV infection. Children with their first positive
results on Western blot or HIV detection tests before
October 1994 were categorized based on the 1987
classification system. Those tested during or after Oc-
tober 1994 are categorized under the revised 1994
pediatric classification system. For children of any age
1Included among the dependencies, possessions, and independent
nations are Puerto Rico, the U.S. Virgin Islands, Guam, American
Samoa, the Republic of Palau, the Republic of the Marshall Islands, the
Commonwealth of the Northern Mariana Islands, and the Federated
States of Micronesia. The latter 5 comprise the category “Pacific Islands,
U.S.” listed in tables 1 and 33.
with an AIDS-defining condition that requires evi-
dence of HIV infection, a single positive HIV-detection
test (i.e., HIV culture, HIV PCR, or HIV antigen [p24])
is sufficient for a reportable AIDS diagnosis if the diag-
nosis is confirmed by a physician.
Although completeness of reporting of diagnosed
AIDS cases to state and local health departments var-
ies by geographic region and patient population, stud-
ies conducted by state and local health departments
indicate that reporting of AIDS cases in most areas of
the United States is more than 85 percent complete (J
Acquir Immune Def Syndr, 1992;5:257-64 and Am J
Public Health 1992;82:1495-99). In addition, multiple
routes of exposure, opportunistic diseases diagnosed
after the initial AIDS case report was submitted to
CDC, and vital status may not be determined or re-
ported for all cases. However, among persons report-
ed with AIDS, reporting of deaths is estimated to be
more than 90 percent complete (JAMA 1996;276:126-
31).
Included in this report are persons known to be in-
fected with human immunodeficiency virus type 2
(HIV-2). See MMWR 1995;44:603-06.
Surveillance of HIV infection
Through December 31, 1997, 27 states had laws or
regulations requiring confidential reporting by name of
all persons with confirmed HIV infection, in addition to
reporting of persons with AIDS. Two other states,
Connecticut and Texas, required reporting by name of
HIV infection only for children less than 13 years of
age; and Oregon required reporting for children less
than 6 years of age. These states initiated reporting at
various times after the development of serum HIV-an-
tibody tests in 1985. Before 1991, surveillance of HIV
infection was not standardized and reporting of HIV in-
fections was based primarily on passive surveillance.
Consequently, many cases reported before 1991 do
not have complete information. Since then, CDC has
assisted states in conducting active surveillance of
HIV infection using standardized report forms and
software. However, collection of demographic and risk
information still varies among states. 
Estimates of the prevalence of HIV infection in the
United States in 1992 were between 650,000 and
900,000 (JAMA 1996;276:126-31). However, HIV sur-
veillance reports may not be representative of all per-
sons estimated to be infected with HIV since not all
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infected persons have been tested; HIV infection data
should be interpreted with caution. Because many
HIV-reporting states also offer anonymous HIV testing
in publicly funded sites and through home collection
HIV test kits, confidential HIV infection reports may
not be representative of all persons being tested in
these areas. Furthermore, many factors may influ-
ence testing patterns, including the extent that testing
is targeted or routinely offered to specific groups and
the availability and access to medical care and testing
services. These data provide a minimum estimate of
the number of persons known to be HIV infected in
states with confidential HIV infection reporting.
For this report, persons greater than 18 months of
age were considered HIV infected if they had at least
one positive Western blot or positive detection test
(culture, antigen, or other detection test) or had a di-
agnosis of HIV infection documented by a physician.
Before October 1994, children less than 15 months of
age were considered HIV infected if they met the def-
inition stated in the 1987 pediatric classification sys-
tem for HIV infection (MMWR 1987;36:225-30, 235).
Beginning October 1994, children less than 18
months of age are considered HIV infected if they
meet the definition stated in the 1994 pediatric classi-
fication system for HIV infection (MMWR 1994;43[no.
RR-12]:1-10). This report also includes children who
were diagnosed by a physician as HIV infected. Al-
though many states monitor reports of children born to
infected mothers, only those with documented diagno-
sis of HIV infection are included in this report. 
Because states initiated reporting on different
dates, the length of time reporting has been in place
will influence the number of HIV infection cases re-
ported. For example, data presented for a given annu-
al period may include cases reported during only a
portion of the year. Prior to statewide HIV reporting,
some states collected reports of HIV infection in se-
lected populations. Therefore, these states have re-
ports prior to initiation of statewide confidential
reporting.  A state with confidential HIV infection re-
porting also may report persons testing positive in that
state who are residents of other states.  Therefore,
when HIV data are presented by state of residence,
persons reported prior to the date a state initiated re-
porting may have been reported from other states with
confidential HIV infection reporting.
Over time, persons with HIV infection will be diag-
nosed and reported with AIDS. HIV infection cases
later reported with AIDS are deleted from the HIV in-
fection tables and added to the AIDS tables. Persons
with HIV infection may be tested at any point in the
clinical spectrum of disease; therefore, the time be-
tween diagnosis of HIV infection and AIDS will vary. In
addition, because surveillance practices differ, report-
ing and updating of clinical and vital status of cases
vary among states. 
Included in this report are persons known to be in-
fected with human immunodeficiency virus type 2
(HIV-2). See MMWR 1995;44:603-06.
Tabulation and presentation of data
Data in this report are provisional. Each issue of this
report includes information received by CDC through
the last day of the reporting period. AIDS data are tab-
ulated by date of report to CDC unless otherwise not-
ed. Data for U.S. dependencies and possessions and
for associated independent nations are included in the
totals. 
Age group tabulations are based on the person’s
age at first documented positive HIV-antibody test re-
sult for HIV infection cases, and age at diagnosis of
AIDS for AIDS cases. Adult/adolescent cases include
persons 13 years of age and older; pediatric cases in-
clude children under 13 years of age. Age group tab-
ulations for AIDS cases in table 14 (year-end edition
only) are based on age at death.
Tabulations of persons living with HIV infection and
AIDS (table 33) include persons whose vital status
was “alive” as of the last update; persons whose vital
status is missing or unknown are not included. Tabu-
lations of deaths in persons with AIDS include per-
sons whose vital status was “dead” as of the last
update; persons whose vital status is missing or un-
known are not included. Caution should be used in in-
terpreting these data because states vary in the
frequency with which they review the vital status of
persons reported with HIV infection and AIDS. In ad-
dition, some cases may be lost to follow-up.
Table 12 (year-end edition only) tabulates AIDS-in-
dicator conditions reported during the last year. These
data are known to underreport AIDS-indicator condi-
tions and should be interpreted with caution. Reported
conditions overrepresent initial AIDS-indicator illness
because follow-up for subsequent indicator diseases
is resource intensive and has not been systematic or
standardized in most health departments. The 1993
AIDS surveillance case definition for adults and ado-
lescents added reporting of HIV-infected persons with
severe HIV-related immunosuppression (CD4+ T-lym-
phocyte count of less than 200/µL or less than 14 per-
cent). Since implementation of the 1993 definition,
reporting of AIDS cases based on AIDS-defining op-
portunistic infections has decreased (AIDS 1994;
8:1489-93).
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Table 2 lists AIDS case counts for each metropoli-
tan area with an estimated 1997 population of
500,000 or more. AIDS case counts for metropolitan
areas with 50,000 to 500,000 population are reported
as a combined subtotal. On December 31, 1992, the
Office of Management and Budget announced new
Metropolitan Statistical Area (MSA) definitions, which
reflect changes in the U.S. population as determined
by the 1990 census. These definitions were updated
most recently on July 1, 1996. The cities and counties
which compose each metropolitan area listed in table
2 are provided in the publication “Metropolitan Areas
as of June 30, 1995” (available by calling the National
Technical Information Service, 1–703–487–4650, and
ordering accession no. PB95-208880 or by visiting
www.census.gov/population/www/methodmet.html).
Standards for defining central and outlying counties of
metropolitan areas were published in the Federal
Register (FR 1990;55:12154-60).
The metropolitan area definitions are the MSAs for
all areas except the 6 New England states. For these
states, the New England County Metropolitan Areas
(NECMA) are used. Metropolitan areas are named for
a central city in the MSA or NECMA, may include sev-
eral cities and counties, and may cross state bound-
aries. For example, AIDS cases and annual rates
presented for the District of Columbia in table 1 in-
clude only persons residing within the geographic
boundaries of the District. AIDS cases and annual
rates for Washington, D.C., in table 2 include persons
residing within the several counties in the metropolitan
area, including counties in Maryland, Virginia, and
West Virginia. State or metropolitan area data tabula-
tions are based on the person’s residence at first pos-
itive HIV-antibody test result for HIV infection cases
and residence at diagnosis of the first AIDS-indicator
condition(s) for AIDS cases.  
Estimates of AIDS-opportunistic illness (AIDS-OI)
incidence (tables 18, 19, and 20), estimated deaths
(tables 21, 22, and 23), and estimated persons living
with AIDS (tables 24, 25, and 26) are not counts of ac-
tual numbers of persons reported to the surveillance
system.  The estimates are adjusted for delays in re-
porting of cases and deaths and are based on a num-
ber of assumptions (for example, see “Estimated
AIDS-opportunistic illness” below).  While these tables
use the best estimates currently available, there is in-
herent uncertainty in these estimates.  Therefore, the
estimates in this report are rounded.  Other analyses
suggest that the uncertainty in these estimates is at
least one percent (J Acquir Immune Def Syndr,
1997;16:116-21).  Therefore, the rounding is to one
percent of the upper limit within arbitrarily chosen
ranges.  State and local surveillance staff are encour-
aged to adopt similar rounding conventions when pre-
senting estimates.  As is standard computational
practice, changes in the estimates of the AIDS-OI in-
cidence, estimates of deaths, and estimates of per-
sons living with AIDS should be computed from
unrounded numbers, rather than from rounded num-
bers.  That is, an estimate, such as the percent
change in annual incidence, should not be computed
from the rounded estimates of AIDS-OI incidence.  An
estimate of change computed from rounded numbers
is especially unreliable if the annual estimates are rel-
atively small.
Exposure categories
For surveillance purposes, HIV infection cases and
AIDS cases are counted only once in a hierarchy of
exposure categories. Persons with more than one re-
ported mode of exposure to HIV are classified in the
exposure category listed first in the hierarchy, except
for men with both a history of sexual contact with other
men and injecting drug use. They make up a separate
exposure category. 
“Men who have sex with men” cases include men
who report sexual contact with other men (i.e., homo-
sexual contact) and men who report sexual contact
with both men and women (i.e., bisexual contact).
“Heterosexual contact” cases are in persons who re-
port specific heterosexual contact with a person with,
or at increased risk for, HIV infection (e.g., an injecting
drug user).
Adults/adolescents born, or who had sex with
someone born, in a country where heterosexual trans-
mission was believed to be the predominant mode of
HIV transmission (formerly classified as Pattern-II
countries by the World Health Organization) are no
longer classified as having heterosexually acquired
AIDS. Similar to case reports for other persons who
are reported without behavioral or transfusion risks for
HIV, these reports are now classified (in the absence
of other risk information which would classify them
into another exposure category) as “no risk reported
or identified” (MMWR 1994;43:155-60). Children
whose mother was born, or whose mother had sex
with someone born, in a Pattern-II country are now
classified (in the absence of other risk information
which would classify them into another exposure cat-
egory) as “Mother with/at risk for HIV infection: has
HIV infection, risk not specified.”
“No risk reported or identified” cases are in persons
with no reported history of exposure to HIV through
any of the routes listed in the hierarchy of exposure
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categories. “Risk not reported or identified” cases in-
clude persons who are currently under investigation
by local health department officials; persons whose
exposure history is incomplete because they died, de-
clined to be interviewed, or were lost to follow-up; and
persons who were interviewed or for whom other fol-
low-up information was available and no exposure
mode was identified. Persons who have an exposure
mode identified at the time of follow-up are reclassi-
fied into the appropriate exposure category. Histori-
cally, investigations and follow up for modes of
exposure by state health departments were conduct-
ed routinely for persons reported with AIDS and as re-
sources allowed for those reported with HIV infection.
Therefore, the percentage of HIV infected persons
with risk not reported or identified is substantially high-
er than for those reported with AIDS.
Estimated AIDS-opportunistic illness
In 1993, the AIDS surveillance case definition was
expanded to include a laboratory measure of severe
immunosuppression (CD4+ T-lymphocyte count of
less than 200 cells/µL or a percent of total lympho-
cytes less than 14) and three additional clinical condi-
tions (pulmonary tuberculosis, recurrent pneumonia,
and invasive cervical cancer). Before 1993, the sur-
veillance definition included only opportunistic illness-
es, and trends in the incidence of AIDS were
evaluated by examining the number of AIDS opportu-
nistic illnesses (AIDS-OIs) diagnosed per year or
quarter, adjusted for reporting delays. Because most
HIV-infected persons become severely immunosup-
pressed before the onset of AIDS-OIs, the addition of
the CD4+ criteria temporarily distorted observed
trends in AIDS incidence. To examine trends over
time, additional adjustments are required to estimate
when an AIDS-OI will develop in persons who were re-
ported based on the CD4+ criteria. CDC has devel-
oped a procedure to estimate the incidence of AIDS-
OIs among persons reported with AIDS based on the
CD4+ criteria. Estimates of trends in AIDS-OIs are dis-
played in tables 18, 19, and 20. Annual estimates are
through the most recent year for which reliable esti-
mates are available. 
The estimated AIDS-OI incidence is the sum of in-
cidence in two groups.  Cases in both groups are ad-
justed for delays in case reporting  The first group is
persons reported to AIDS surveillance with AIDS-OIs.
The second group is persons reported with AIDS
based on a CD4+ count or percent. Most of these per-
sons will eventually have an AIDS-OI diagnosed. CDC
has estimated the number of persons who had or will
have an AIDS-OI diagnosed after the date of the re-
ported CD4+ count or percent, by month of AIDS-OI
diagnosis. To do this, CDC used data from the Adult
Spectrum of Disease Project (JAMA 1992; 267:1798-
1805) to estimate the probability distribution of the
time interval between a CD4+ count in a particular
range (e.g., 0 to 29 cells/µL, 30 to 59 cells/µL, etc.)
and the diagnosis of an AIDS-OI, taking into account
the possibility of death before an AIDS-OI diagnosis.
This probability distribution is the proportion of per-
sons with a CD4+ count in a given range who will have
an AIDS-OI diagnosed 1 month, 2 months, etc., after
the reported CD4+ count. The expected number of
persons with an AIDS-OI diagnosed in each later
month among persons whose CD4+ count was in a
particular range during a given month is the product of
the number of these persons and the proportion ex-
pected to have an AIDS-OI diagnosed in this later
month. The estimate of the number of AIDS-OI diag-
noses in a particular month among persons reported
with AIDS based on the CD4+ criteria is the sum, over
all combinations of CD4+ ranges and previous
months, of the number of persons expected to be di-
agnosed with an AIDS-OI in the month for which the
estimate is made.
There is uncertainty in these estimates of AIDS-OI
incidence. Some uncertainty is the result of the need
to adjust for delays in reporting of AIDS cases. Other
persons reported with AIDS based on the CD4+ cri-
teria have an unreported AIDS-OI diagnosis by the
date of the CD4+ determination; the estimation proce-
dure counts their contribution to AIDS-OI incidence
later than it should. However, preliminary analyses
show that this source of bias changes estimated
AIDS-OI incidence by only a few percentage points.
Recent advances in HIV treatment may also be affect-
ing AIDS-OI incidence.  The actual decline in AIDS-OI
incidence may be greater than the estimates in this re-
port because there are insufficient longitudinal clinical
data to model the impact of the newly available anti-
retroviral therapies on AIDS-OI incidence.
Recently reported AIDS cases are more likely to be
reported with risk not reported or identified (NIR). Re-
cent AIDS incidence in some exposure categories,
therefore, will be underestimated unless an adjust-
ment is made. The adjustment of NIR adult/adoles-
cent cases is based on the sex-, race-, and region-
specific exposure category redistributions of cases di-
agnosed from 1989 through 1995 that were initially
assigned to the NIR category but have subsequently
been reclassified.  Similar adjustment of NIR pediatric
cases are based on exposure category redistribution
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of all cases diagnosed between 1989 through 1995
and subsequently reclassified.  See J Acquir Immune
Def Syndr, 1992;5:547-55 and J Acquir Immune Def
Syndr, 1997;14:465-74. 
The regions of residence included in table 18, 21,
and 24 are defined as follows. Northeast: Connecticut,
Maine, Massachusetts, New Hampshire, New Jersey,
New York, Pennsylvania, Rhode Island, and Vermont;
Midwest: Indiana, Illinois, Iowa, Kansas, Michigan,
Minnesota, Missouri, Nebraska, North Dakota, Ohio,
South Dakota, and Wisconsin; South: Alabama, Ar-
kansas, Delaware, District of Columbia, Florida, Geor-
gia, Kentucky, Louisiana, Maryland, Mississippi, North
Carolina, Oklahoma, South Carolina, Tennessee,
Texas, Virginia, and West Virginia; West: Alaska, Ari-
zona, California, Colorado, Idaho, Hawaii, Montana,
Nevada, New Mexico, Oregon, Utah, Washington,
and Wyoming; Territories: Guam, Puerto Rico, the
U.S. Virgin Islands, and the U.S. Pacific Islands listed
on page 39.
Reporting delays
Reporting delays (time between diagnosis of HIV
infection or AIDS and report to CDC) may vary among
exposure, geographic, racial/ethnic, age and sex cat-
egories, and have been as long as several years for
some AIDS cases. About 50 percent of all AIDS cases
were reported to CDC within 3 months of diagnosis
and about 80 percent were reported within 1 year.
Among persons with AIDS, estimates in delay of re-
porting of deaths show that approximately 90 percent
of deaths are reported within 1 year. For HIV infection
cases diagnosed since implementation of uniform re-
porting through the HIV/AIDS Reporting System on
January 1, 1994, about 70 percent of all HIV infection
cases were reported to CDC within 3 months of diag-
nosis and about 95 percent were reported within 1
year.  See MMWR  1998;47:309-14.
Reporting delay adjustments to tables 18 through
26 were estimated by a maximum likelihood statistical
procedure, taking into account differences in reporting
delays among exposure, geographic, racial/ethnic,
age, sex, and vital status at diagnosis categories, but
assuming that reporting delays within these groups
have not changed over time (Statist Med
1998;17:143-54 and Lecture Notes in Biomathemat-
ics 1989;83:58-88).
Rates
Rates are calculated for 12-month period per
100,000 population for AIDS cases only. Rates are
not calculated for HIV infection reports because case
counts for HIV infection are believed to be less com-
plete than AIDS case counts. Population denomina-
tors for computing AIDS rates for the 50 states and the
District of Columbia are based on official postcensus
estimates from the U.S. Bureau of Census. Denomi-
nators for U.S. dependencies and possessions and
associated independent nations are linear extrapola-
tions of official 1980 and 1990 census counts.   Each
12-month rate is the number of cases reported during
the 12-month period, divided by the 1996 or 1997 pop-
ulation, multiplied by 100,000.   The denominators for
computing race-specific rates (table 10, year-end edi-
tion only) are based on 1997 census estimates pub-
lished in U.S. Bureau of Census publication PPL-91,
“U.S. Population Estimates by Age, Sex, Race, and
Hispanic Origin: 1990 to 1997.”  Race-specific rates
are the number of cases reported for a particular ra-
cial/ethnic group during the preceding 12-month peri-
od divided by the projected population for that race/
ethnicity, multiplied by 100,000.
Case-fatality rates are calculated for each half-year
by date of diagnosis of AIDS. Each 6-month case-fa-
tality rate is the number of deaths ever reported
among cases diagnosed in that period (regardless of
the year of death), divided by the number of total cas-
es diagnosed in that period, multiplied by 100. Report-
ed deaths are not necessarily caused by HIV-related
disease. Caution should be used in interpreting case-
fatality rates because reporting of deaths is incom-
plete (Am J Public Health 1992;82:1500-05 and Am J
Public Health 1990;80:1080-86).
